Leiomyoma of uterus

CD2_BENIGN_LEIOMYOMA_UTERI

uterine fibroid: A benign smooth muscle neoplasm arising from the body of the uterus. It is characterized by the presence of spindle cells with cigar-shaped nuclei, interlacing fascicles, and a whorled pattern.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D25 Hospital discharge: ICD-9 — 218 Hospital discharge: ICD-8 — 21899 Cause of death: ICD-10 — D25 Cause of death: ICD-9 — 218 Cause of death: ICD-8 — 21899 2 out of 7 registries used, show all original rules.	43521
4. Check minimum number of events None	43521
5. Include endpoints None	43521
6. Filter based on genotype QC (FinnGen only)	43521

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D10-D36
Name in latin: Leiomyoma uteri

NAME	CD2_BENIGN_LEIOMYOMA_UTERI
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D25
HD_ICD_9	218
HD_ICD_8	21899
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D25
COD_ICD_9	218
COD_ICD_8	21899
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Leiomyoma of uterus based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	302635	302635	-
Only index persons	283123	283123	-
Unadjusted period prevalence (%)
Whole population	8.67	8.67	-
Only index persons	10.41	10.41	-
Median age at first event (years)
Whole population	-	46.91	-
Only index persons	-	46.75	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	43521	43521	-
Unadjusted period prevalence (%)	14.83	14.83	-
Median age at first event (years)	46.68	46.68	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10545: Matched controls
73639

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

9.0

323.0

1041

889

D25.2

ICD-10 Finland

Subserosal leiomyoma of uterus

153.0

323.0

1307

LCD00

NOMESCO Finland

Hysterectomy

11.8

323.0

1035

672

D25.0

ICD-10 Finland

Submucous leiomyoma of uterus

367.9

323.0

2513

LCB14

NOMESCO Finland

Laparoscopic myolysis

84.3

323.0

689

21899

ICD-8 Finland

Uterine fibroma

+∞

323.0

485

LBE20

NOMESCO Finland

Laparoscopic bilateral salpingectomy

12.8

323.0

864

509

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

9.6

323.0

1314

1077

B02AA02

ATC

tranexamic acid; systemic

3.4

323.0

3629

9789

D25.1

ICD-10 Finland

Intramural leiomyoma of uterus

114.7

323.0

3464

313

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

302.2

323.0

6433

379

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

4.0

323.0

3164

7180

LCA06

NOMESCO Finland

Biopsy of endometrium

5.0

323.0

3758

7339

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

3.0

323.0

6219

23766

G03XB02

ATC

ulipristal; oral (progesterone receptor modulators)

152.0

313.8

378

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

3.5

311.3

1793

4126

LCB10

NOMESCO Finland

Myomectomy

114.6

308.3

380

D25

ICD-10 Finland

Leiomyoma of uterus

14.9

295.3

556

274

LBE01

NOMESCO Finland

Laparoscopic salpingectomy

4.8

265.3

1017

1595

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

3.5

242.3

1356

3004

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.7

240.6

2055

6084

LCB11

NOMESCO Finland

Laparoscopic myomectomy

222.0

235.3

277

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

4.1

229.6

1027

1871

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

3.5

219.4

1189

2556

LCD10

NOMESCO Finland

Vaginal hysterectomy

5.2

197.1

696

986

LCD97

NOMESCO Finland

Other laparoscopic hysterectomy

118.8

189.6

233

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

2.3

173.0

2048

7071

2180A

ICD-9 Finland

Uterine leiomyoma, Submucous leiomyoma of uterus

+∞

171.1

189

N84.0

ICD-10 Finland

Polyp of corpus uteri

3.0

168.5

1154

2918

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

165.5

2551

9873

LBE00

NOMESCO Finland

Salpingectomy

10.9

153.4

330

218

N92.4

ICD-10 Finland

Excessive bleeding in the premenopausal period

3.0

123.6

802

1936

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.6

116.9

3597

33813

O34.1

ICD-10 Finland

Maternal care for tumour of corpus uteri

10.6

116.3

252

169

N02BE01

ATC

paracetamol; systemic, rectal

1.8

113.4

8740

53681

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.6

109.6

2539

25605

WX402

NOMESCO Finland

General anaesthesia

1.9

107.3

1799

7032

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

107.1

2524

11100

ULC02

NOMESCO Finland

Hysteroscopy

2.6

105.7

896

2549

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.9

101.7

1744

6860

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.8

100.1

2030

8468

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.6

98.8

3805

19156

B01AB05

ATC

enoxaparin; parenteral

1.7

97.1

2408

10704

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

3.3

90.6

517

1133

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

87.6

1116

3875

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.6

86.3

1373

15383

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.1

84.0

1080

3762

TLC02

NOMESCO Finland

Simple extraction of IUD

2.1

77.9

985

3400

N80.1

ICD-10 Finland

Endometriosis of ovary

2.5

74.3

677

1994

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

3.0

73.1

468

1112

LCD11

NOMESCO Finland

Laparoscopically assisted vaginal hysterectomy

7.9

71.4

181

162

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.7

70.3

1990

9067

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.9

69.5

1192

4633

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.6

68.1

1427

15102

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

2.3

67.7

681

2107

MAX99

NOMESCO Finland

Assistance to normal delivery

0.5

66.1

576

7703

LBE10

NOMESCO Finland

Bilateral salpingectomy

25.4

64.7

101

N80.0

ICD-10 Finland

Endometriosis of uterus

2.9

64.5

447

1118

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.9

61.4

413

1013

W78

ICPC

Pregnancy

0.5

59.6

764

9166

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

4.7

59.3

222

333

SPAT1197

SPAT

Extensive health check-up of expecting family

0.5

59.3

636

8014

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

0.6

58.5

1271

13410

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

57.3

2891

15013

Z39.2

ICD-10 Finland

Routine postpartum follow-up

0.6

52.1

867

9765

LCA10

NOMESCO Finland

Curettage of body of uterus

2.5

50.6

431

1220

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

0.6

49.3

1009

10841

SPAT1196

SPAT

Monitoring of normal pregnancy

0.5

47.2

375

5192

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.3

47.1

262

563

PD2DT

NOMESCO Finland

Embolisation of gynekological tumor

193.6

46.6

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

46.3

317

786

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

5.3

45.9

154

205

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.0

45.7

288

676

D39.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Uterus

7.1

44.8

121

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

0.5

44.5

491

6169

LDA00

NOMESCO Finland

Dilatation of cervix uteri

4.4

44.2

176

283

P01AB01

ATC

metronidazole; oral, rectal

1.3

42.7

4316

25035

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

42.5

2876

15606

LCB98

NOMESCO Finland

Other transluminal endoscopic excision of lesion of uterus

3.8

42.1

198

372

SPAT1308

SPAT

Sexual health counselling

0.6

41.4

836

9045

WX307

NOMESCO Finland

Obstetric epidural analgesia

0.5

41.3

386

5094

Z30.4

ICD-10 Finland

Surveillance of contraceptive drugs

0.4

41.2

227

3561

X78

ICPC

Fibromyoma uterus

27.2

40.7

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

3.4

39.5

207

426

B01AB10

ATC

tinzaparin; parenteral

2.1

39.4

483

1633

Z37.0

ICD-10 Finland

Single live birth

0.6

38.0

900

9424

LAF01

NOMESCO Finland

Laparoscopic unilateral salpingo-oophorectomy

2.3

37.8

391

1222

R2110

NOMESCO Finland

Giving the first information

1.7

36.7

927

4033

SPAT1380

SPAT

Postpartum check-up

0.5

36.3

393

4978

SPAT1379

SPAT

Health check-up of pregnant person

0.6

35.4

504

5934

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

2.1

34.9

425

1433

WX704

NOMESCO Finland

Intubation

1.8

34.9

632

2479

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

34.8

9502

63185

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

34.0

579

2225

LAF00

NOMESCO Finland

Unilateral salpingo-oophorectomy

3.4

33.2

173

355

W12

ICPC

Contraception intrauterine

0.6

33.2

850

8777

Z34.9

ICD-10 Finland

Supervision of normal pregnancy, unspecified

0.7

32.6

1046

10351

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.7

32.5

250

668

LCB20

NOMESCO Finland

Transvaginal myomectomy

39.4

32.1

W11

ICPC

Contraception oral

0.5

31.8

323

4170

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

30.9

545

2118

WX321

NOMESCO Finland

Acute spinal anesthesia for delivery

0.4

30.8

159

2556

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.4

30.4

1713

8909

O81.4

ICD-10 Finland

Vacuum extractor delivery

0.6

29.8

455

5279

8302

FHL

Tumor removal (e.g., enucleation) or polyp removal

19.1

29.3

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

2.3

29.3

283

858

C08CA01

ATC

amlodipine; oral

1.4

27.9

1467

7522

SPAT1190

SPAT

Insertion or removal of intrauterine contraceptive device

0.6

27.8

446

5113

JAH01

NOMESCO Finland

Laparoscopy

1.7

25.7

599

2539

MAE00

NOMESCO Finland

Outlet vacuum delivery

0.6

25.3

367

4316

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

25.2

721

3233

LCC10

NOMESCO Finland

Supravaginal hysterectomy

8.3

24.6

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

0.6

24.5

609

6352

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.0

24.0

330

1170

Z34

ICD-10 Finland

Supervision of normal pregnancy

0.5

23.1

200

2707

X06

ICPC

Menstruation excessive

2.2

23.0

243

772

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

2.0

22.6

297

1036

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

4.3

22.3

143

ZXA10

NOMESCO Finland

Bilateral

1.4

21.7

1198

6177

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

21.6

233

747

ZXC40

NOMESCO Finland

Use of ultrasound

4.0

21.5

158

A02BC02

ATC

pantoprazole; systemic

1.2

21.2

5552

35074

TMA00

NOMESCO Finland

Episiotomy

0.5

20.4

160

2229

G03DC03

ATC

lynestrenol; oral

1.9

20.3

330

1248

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

0.8

20.1

1305

11640

W90

ICPC

Uncompl labour/delivery livebirth

0.5

20.0

148

2105

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

3.1

20.0

118

268

N02AX02

ATC

tramadol; systemic, rectal

1.2

19.9

3106

18526

N920, D259

ICD-10 Finland

+∞

19.9

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

0.7

19.8

906

8506

62533

ICD-8 Finland

Other diseases of uterus, Adenomyosis uteri

11.4

19.4

LDB00

NOMESCO Finland

Excision of lesion of cervix uteri

2.4

19.4

171

497

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

19.0

3470

21028

N921, D250

ICD-10 Finland

+∞

19.0

LBF01

NOMESCO Finland

Laparoscopic perfusion of Fallopian tube

1.9

18.8

295

1104

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

0.7

18.8

854

8026

XMA22

NOMESCO Finland

General examination of pregnant woman

0.7

18.2

614

6064

N73.6

ICD-10 Finland

Female pelvic peritoneal adhesions

2.5

18.1

155

445

M01AH05

ATC

etoricoxib; oral

1.2

17.8

5611

35806

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

2.1

17.8

224

771

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

0.7

17.6

727

6941

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

17.4

1337

7263

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

1.2

17.4

2570

15188

UJF32

NOMESCO Finland

Coloscopy

1.3

17.3

1462

8053

JAL21

NOMESCO Finland

Laparoscopic excision or destruction of lesion of peritoneum

2.0

17.2

234

830

SPAT1153

SPAT

Removal of sutures

1.3

17.2

1859

10586

SPAT1193

SPAT

Pap smear

0.7

16.7

988

8941

D50

ICD-10 Finland

Iron deficiency anaemia

2.1

16.4

205

705

WX725

NOMESCO Finland

Noninvasive ventilation

1.8

16.0

313

1262

N25.9

ICD-10 Finland

Disorder resulting from impaired renal tubular function, unspecified

38.5

15.9

N80.9

ICD-10 Finland

Endometriosis, unspecified

1.8

15.8

306

1231

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

0.7

15.7

847

7773

O48

ICD-10 Finland

Prolonged pregnancy

0.6

15.6

210

2513

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

15.5

512

2377

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.2

15.5

159

502

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

5.4

15.4

C09CA01

ATC

losartan; oral

1.3

15.3

1069

5721

S18

ICPC

Laceration/cut

1.2

15.2

2536

15147

O99.80

ICD-10 Finland

The fear of childbirth

0.6

15.1

337

3601

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

0.7

14.9

359

3776

A02BC05

ATC

esomeprazole; systemic

1.2

14.7

3319

20408

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.4

14.6

886

4630

N84.1

ICD-10 Finland

Polyp of cervix uteri

1.8

14.6

264

1040

N70.1

ICD-10 Finland

Chronic salpingitis and oophoritis

2.2

14.5

157

509

M01AE02

ATC

naproxen; oral, rectal

1.2

14.4

5500

35389

O68.0

ICD-10 Finland

Labour and delivery complicated by fetal heart rate anomaly

0.7

14.4

409

4165

C07AB07

ATC

bisoprolol; oral

1.2

14.4

2410

14387

O80.8

ICD-10 Finland

Other single spontaneous delivery

0.6

14.1

256

2857

N97.8

ICD-10 Finland

Female infertility of other origin

1.7

13.9

274

1111

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.5

13.8

480

2256

WX110

NOMESCO Finland

Local anesthesy

1.2

13.8

6645

43519

WX702

NOMESCO Finland

Supraglottic ventilation device

1.6

13.7

419

1914

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

4.1

13.6

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

13.5

630

3144

8113

FHL

Fractional scraping

2.1

13.3

164

562

W14

ICPC

Contraception female other

0.6

13.1

211

2418

WX400

NOMESCO Finland

Inhalation anesthesy

1.5

13.0

401

1834

N92.5

ICD-10 Finland

Other specified irregular menstruation

1.5

12.9

409

1884

205

Kela drug reimbursment

Chronic hypertension

1.3

12.8

856

4544

O63.1

ICD-10 Finland

Prolonged second stage (of labour)

0.6

12.7

208

2375

SPAT1357

SPAT

Monitoring of problem during pregnancy

0.5

12.6

133

1695

N80.4

ICD-10 Finland

Endometriosis of rectovaginal septum and vagina

1.9

12.5

199

753

C54.21

ICD-10 Finland

Leiomyosarcoma and myometrium

39.6

12.4

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

2.3

12.3

114

343

C09CA06

ATC

candesartan; oral

1.2

12.3

1549

8950

LAE11

NOMESCO Finland

Unilateral laparoscopic oophorectomy

2.8

12.2

199

SPAT1200

SPAT

Guidance for breast-feeding and breast care

0.5

12.1

1262

62530

ICD-8 Finland

Other diseases of uterus, Endometriosis ovarii

10.3

12.1

G03DA02

ATC

medroxyprogesterone; systemic (pregnen (4) derivatives)

1.5

12.1

480

2324

C10AA07

ATC

rosuvastatin; oral

1.3

12.1

807

4286

Z32.1

ICD-10 Finland

Pregnancy confirmed

0.8

12.0

883

7788

SPAT1192

SPAT

Gynaecological examination

0.8

11.8

845

7479

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.2

11.8

118

369

N85.0

ICD-10 Finland

Endometrial glandular hyperplasia

1.9

11.6

168

614

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

0.8

11.6

1004

8688

A02BC03

ATC

lansoprazole; oral

1.2

11.6

2088

12518

LEE00

NOMESCO Finland

Suture of vagina

4.9

11.5

LAC00

NOMESCO Finland

Excision of ovarian cyst

3.2

11.5

132

LAC21

NOMESCO Finland

Laparoscopic destruction of lesion of ovary

2.0

11.3

151

537

W85

ICPC

Gestational diabetes

0.6

11.2

182

2080

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

11.0

463

2266

N97.9

ICD-10 Finland

Female infertility, unspecified

1.3

11.0

898

4909

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

1.8

11.0

189

735

G03DC02

ATC

norethisterone; oral

1.3

10.9

771

4129

M01AB05

ATC

diclofenac; systemic, rectal

1.2

10.9

6336

41675

H01CA02

ATC

nafarelin; nasal

1.4

10.8

451

2205

LGA21

NOMESCO Finland

Laparoscopic sterilisation by constriction of Fallopian tubes

1.3

10.7

815

4409

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

10.6

826

4488

W84

ICPC

Pregnancy high risk

0.6

10.5

150

1767

G03DA04

ATC

progesterone; systemic, rectal, vaginal

1.4

10.5

513

2584

J01DB01

ATC

cefalexin; oral

1.2

10.5

7942

53195

XLA10

NOMESCO Finland

1.4

10.4

651

3419

M03BX02

ATC

tizanidine; oral

1.1

10.2

6372

42012

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

10.2

2934

18284

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

10.2

708

3780

C10AA05

ATC

atorvastatin; oral

1.3

10.2

1092

6184

JN4BD

NOMESCO Finland

Extensive body CT

1.4

10.2

417

2033

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

10.2

751

4048

62620

ICD-8 Finland

Disorders of menstruation, Excessive

4.1

10.1

62660

ICD-8 Finland

Disorders of menstruation, Intermenstrual bleeding

2.8

10.1

170

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.7

10.1

209

865

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

10.0

373

1783

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

10.0

1788

10695

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

2.5

10.0

233

D39.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified

3.9

10.0

N921, D259

ICD-10 Finland

+∞

9.9

N920, D250

ICD-10 Finland

+∞

9.9

SPAT1399

SPAT

Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.

0.6

9.8

127

1532

SPAT1189

SPAT

Other ultrasound examination during pregnancy

0.6

9.8

124

1502

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.7

9.6

298

2985

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

1.6

9.6

253

1118

D26.1

ICD-10 Finland

Other benign neoplasm: Corpus uteri

6.3

9.5

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

9.5

389

1896

O42.9

ICD-10 Finland

Premature rupture of membranes, unspecified

0.7

9.5

218

2312

62699

ICD-8 Finland

Disorders of menstruation, Other

2.6

9.4

191

N83.1

ICD-10 Finland

Corpus luteum cyst

1.7

9.3

200

835

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

9.3

395

1941

Z30.0

ICD-10 Finland

General counselling and advice on contraception

0.7

9.3

504

4627

WX002

NOMESCO Finland

Sedation and analgesia

1.2

9.2

1059

6050

N97.1

ICD-10 Finland

Female infertility of tubal origin

1.8

9.1

166

661

M03BC51

ATC

orphenadrine, combinations; systemic

1.2

9.1

2702

16854

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

4.4

9.1

G47.3

ICD-10 Finland

Sleep apnoea

1.2

9.1

1146

6609

C09DA06

ATC

candesartan and diuretics; oral

1.5

9.0

289

1339

62551

ICD-8 Finland

76.9

8.9

ZXC96

NOMESCO Finland

Robot assisted procedure

2.4

8.9

231

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.4

8.8

416

2086

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

8.8

1367

8058

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

2.0

8.8

111

390

R42

ICD-10 Finland

Dizziness and giddiness

1.2

8.7

1327

7806

N80.5

ICD-10 Finland

Endometriosis of intestine

2.2

8.7

274

C09DA01

ATC

losartan and diuretics; oral

1.4

8.7

374

1845

N97.2

ICD-10 Finland

Female infertility of uterine origin

4.2

8.6

O70.1

ICD-10 Finland

Second degree perineal laceration during delivery

0.6

8.6

127

1481

LCA16

NOMESCO Finland

Destruction of endometrium

1.6

8.5

238

1070

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

0.8

8.4

623

5497

WX720

NOMESCO Finland

Own respiration

1.6

8.4

219

967

D26.9

ICD-10 Finland

Other benign neoplasm: Uterus, unspecified

8.3

8.4

UKC02

NOMESCO Finland

Cystoscopy

1.3

8.4

531

2797

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

8.4

2304

14273

61610

ICD-8 Finland

Diseases of parametrium and pelvic peritoneum (female), Pelvic peritoneal adhesions, female

5.8

8.4

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.1

8.3

3872

24891

TLW99

NOMESCO Finland

Other minor surgical procedure in gynaecology

1.6

8.3

198

854

KCH01

NOMESCO Finland

Percutaneous endoscopic suture of bladder

11.2

8.3

Z36.4

ICD-10 Finland

Antenatal screening for fetal growth retardation using ultrasound and other physical methods

0.6

8.2

1214

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

8.2

386

1936

N926, D259

ICD-10 Finland

+∞

8.1

O36.5

ICD-10 Finland

Maternal care for poor fetal growth

0.7

8.1

202

2103

C08CA13

ATC

lercanidipine; oral

1.4

8.0

423

2164

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

8.0

1565

9421

ZXA00

NOMESCO Finland

Right side

1.2

8.0

1487

8914

L02AE02

ATC

leuprorelin; implant, parenteral

1.5

8.0

237

1083

C54.22

ICD-10 Finland

Endometrial stromal cell sarcoma

14.0

7.9

O47.1

ICD-10 Finland

False labour at or after 37 completed weeks of gestation

0.7

7.9

296

2873

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

1.6

7.9

204

900

WX320

NOMESCO Finland

Spinalanesthesy

1.2

7.9

1417

8466

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

7.9

1755

10681

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

7.9

2384

14869

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

7.8

140

557

J01AA02

ATC

doxycycline; systemic

1.1

7.7

7540

50669

D27.91

ICD-10 Finland

Benign epithelial tumor of the ovary (ovary)

2.0

7.7

327

Y60.0

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during surgical operation

3.4

7.6

8811

FHL

Cesarean section

1.3

7.6

613

3349

N02AJ06

ATC

codeine and paracetamol; systemic

1.1

7.6

2979

18916

O64.0

ICD-10 Finland

Obstructed labour due to incomplete rotation of fetal head

0.6

7.5

131

1468

LAA10

NOMESCO Finland

Percutaneous or transvaginal puncture and recovery of oocyte

1.4

7.5

311

1524

N03AX16

ATC

pregabalin; oral

1.2

7.5

1638

9952

SPAT1316

SPAT

Extensive health check-up of children and adolescents

0.6

7.5

164

1751

8308

FHL

Hysterectomy and bilateral adnexal removal

4.0

7.5

XLD10

NOMESCO Finland

Gynaecological examination

2.6

7.4

139

1413

FHL

Laparoscopy and other therapeutic procedure

1.6

7.4

198

883

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

7.4

442

2314

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.1

7.3

2522

15860

N92

ICD-10 Finland

Excessive, frequent and irregular menstruation

1.6

7.3

182

797

N920, D251

ICD-10 Finland

+∞

7.2

M01AC06

ATC

meloxicam; systemic, rectal

1.1

7.2

2805

17784

M01AH01

ATC

celecoxib; oral (coxibs)

1.2

7.1

1132

6684

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

7.1

753

4260

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

0.7

7.1

297

2826

N80.81

ICD-10 Finland

Endometriosis in sacrouteral ligament

2.3

7.1

182

Z54.0

ICD-10 Finland

Convalescence following surgery

1.8

7.0

127

507

XF402

NOMESCO Finland

ECG with work load test

1.4

7.0

325

1629

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

7.0

431

2264

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

2.4

7.0

170

M79.6

ICD-10 Finland

Pain in limb

1.1

7.0

2889

18387

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

2.2

7.0

230

SPAT1195

SPAT

Antenatal classes

0.6

6.9

109

1250

D06

ICPC

Abdominal pain localized other

1.3

6.9

550

2999

N03AX12

ATC

gabapentin; oral

1.2

6.9

1043

6130

O75.6

ICD-10 Finland

Delayed delivery after spontaneous or unspecified rupture of membranes

0.5

6.9

635

M01AX05

ATC

glucosamine; oral

1.3

6.9

533

2900

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

2.4

6.8

175

MAC96

NOMESCO Finland

Other induction or advancement of labour

0.7

6.8

193

1959

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

6.8

1507

9166

ZXA05

NOMESCO Finland

Left side

1.2

6.7

1367

8254

G03GA06

ATC

follitropin beta; parenteral

1.3

6.7

454

2424

J01MA02

ATC

ciprofloxacin; systemic

1.1

6.6

2637

16727

JN4AD

NOMESCO Finland

Body CT examination

1.5

6.6

243

1165

G03GA01

ATC

chorionic gonadotrophin; parenteral

1.3

6.6

654

3670

SPAT1315

SPAT

Periodic health check-up of children and adolescents

0.6

6.6

109

1233

R33

ICD-10 Finland

Retention of urine

1.6

6.6

171

756

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

0.6

6.6

995

MAC01

NOMESCO Finland

Rupture of aminiotic membrane for induction of labor

0.5

6.6

828

N05CF02

ATC

zolpidem; oral

1.2

6.6

1488

9066

L02AE03

ATC

goserelin; implant

1.7

6.6

135

563

O75.0

ICD-10 Finland

Maternal distress during labour and delivery

0.5

6.5

760

22099

ICD-8 Finland

Benign neoplasm of ovary, Other and unspecified

2.6

6.4

120

X80

ICPC

Benign neoplasm female genital

6.3

6.4

1410

FHL

Laparoscopy

1.5

6.4

210

983

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

1.7

6.4

123

501

N39.3

ICD-10 Finland

Stress incontinence

1.3

6.4

576

3197

Z30.8

ICD-10 Finland

Other contraceptive management

0.6

6.4

1074

N05AH02

ATC

clozapine; systemic

0.5

6.4

660

KH1AD

NOMESCO Finland

CT of urinary organs

1.6

6.3

157

687

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

2.2

6.3

192

R103, D259

ICD-10 Finland

+∞

6.3

Z30

ICD-10 Finland

Contraceptive management

0.6

6.2

109

1216

TLC00

SPAT

0.4

6.2

496

L15

ICPC

Knee symptom/complaint

1.2

6.2

1134

6784

KC1GB

NOMESCO Finland

Cystography with X-ray

4.8

6.2

W29

ICPC

Pregnancy symptom/complaint other

0.6

6.1

101

1140

61520

ICD-8 Finland

Other diseases of ovary and Fallopian tube, Cysta (cystis) follicularis ovarii (retentio)

3.1

6.1

L02AE01

ATC

buserelin; implant, nasal, parenteral

1.5

6.1

197

920

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

0.9

6.1

1419

11242

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

6.1

760

4382

K66.0

ICD-10 Finland

Peritoneal adhesions

2.4

6.0

143

KBH20

NOMESCO Finland

Replantation of ureter

4.7

6.0

N94.4

ICD-10 Finland

Primary dysmenorrhoea

1.6

6.0

154

683

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

15406

69718

1.48

236.40

2.2

2.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3809

13324

1.71

169.44

2.9

3.5

u/ml

43.7

55.0

1.80

3686

12859

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

15139

71484

1.38

157.04

3.7

3.8

—

(3044640) Blood type and Crossmatch panel - Blood

10619

47765

1.39

143.49

2.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

30034

161841

1.67

130.14

14.9

14.0

mmol/l

139.8

139.7

5.25

29359

157923

(3023103) Potassium [Moles/volume] in Serum or Plasma

30100

162295

1.68

130.01

15.1

14.1

mmol/l

3.9

5.26

29371

158067

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1816

5681

1.87

115.13

1.4

pmol/l

111.9

148.4

2.25

1776

5547

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

8029

35490

1.38

114.60

2.1

2.2

—

(3013512) EKG study

9089

41669

1.33

99.62

3.8

3.5

—

(3002256) Pathology report gross observation

5022

21003

1.42

96.39

1.3

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

20393

104648

1.29

92.56

4.8

4.5

e6/l

1653.1

2205.3

0.83

209

1248

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

27794

149070

1.40

91.92

12.6

11.7

ml/min/173m2

80.8

82.0

17.58

23209

122853

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

23327

122322

1.29

84.87

7.4

7.2

u/l

76.9

77.2

0.55

21802

115393

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

26883

143886

1.35

83.35

5.7

5.2

mmol/mol

39.2

38.9

6.51

24595

134104

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

28457

153913

1.39

79.67

4.7

4.3

mmol/l

5.8

11.69

25848

142321

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4255

18072

1.39

72.72

4.6

4.2

33.0

33.1

0.40

2862

12546

(3037467) Urinalysis macro (dipstick) panel - Urine

20860

108698

1.25

72.40

4.7

4.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

30602

168193

1.53

72.03

15.6

14.6

umol/l

69.1

0.15

30591

168108

(3013707) Erythrocyte sedimentation rate by Westergren method

23021

121841

1.25

65.36

4.3

4.1

mm/h

11.9

12.4

7.24

21278

113742

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

28216

153305

1.34

64.10

5.6

5.3

mu/l

2.1

2.0

0.14

25918

143015

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

29128

159137

1.37

62.39

13.6

12.8

mg/l

20.7

20.4

0.54

23197

124428

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

13953

70240

1.23

62.37

5.4

5.2

mmol/l

1.2

16.47

12439

63782

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

30653

168999

1.49

62.37

10.8

10.0

u/l

24.6

23.9

6.52

29532

163764

(3032080) INR in Blood by Coagulation assay

11268

55600

1.23

60.34

7.3

7.1

inr

1.2

0.53

3303

16298

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

15870

81137

1.22

59.92

5.7

umol/l

10.1

0.10

14961

76663

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

29287

160295

1.37

59.82

5.1

4.6

mmol/l

2.9

3.89

26757

149059

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

15347

78213

1.22

59.76

6.1

5.8

mmol/l

1.2

14.65

12783

66082

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

28843

157580

1.34

58.36

4.6

4.2

mmol/l

4.9

8.47

26485

147283

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

6282

43217

0.79

57.22

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

28649

156477

1.33

56.55

4.6

4.1

mmol/l

1.6

3.73

26161

145778

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

27712

150725

1.30

55.67

4.0

3.7

mmol/l

1.3

1.2

60.16

25067

139569

(40761511) CBC panel - Blood by Automated count

30145

166036

1.41

55.46

13.1

12.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

16677

86203

1.20

53.42

4.0

4.1

mmol/l

6.6

6.5

0.51

15648

80231

(3019225) pH of Specimen

3456

14878

1.36

53.04

4.0

3.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

25071

135011

1.24

51.90

4.7

4.5

pmol/l

14.8

14.6

11.04

22881

125155

(3007461) Platelets [#/volume] in Blood

31669

176383

1.64

51.65

20.7

19.1

e9/l

267.9

265.0

11.53

30960

172185

(3024731) MCV [Entitic volume]

31681

176506

1.63

50.75

20.6

19.0

90.6

91.0

41.78

31273

174312

(3010813) Leukocytes [#/volume] in Blood

31686

176542

1.63

50.72

20.7

19.1

e9/l

6.6

6.5

1.34

30892

171884

(3026361) Erythrocytes [#/volume] in Blood

31682

176518

1.63

50.63

20.6

19.1

e12/l

4.4

24.58

30882

171902

(3035941) MCH [Entitic mass]

31678

176492

1.63

50.59

20.6

19.0

30.0

30.2

48.61

31271

174302

(3000963) Hemoglobin [Mass/volume] in Blood

31687

176562

1.63

50.42

20.8

19.2

g/l

132.4

132.3

0.45

31291

174407

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

557

5797

0.54

43.93

1.4

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

8415

41488

1.21

41.34

3.8

3.7

mg/mmol

8.0

7.6

0.24

4729

23804

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

7921

38830

1.21

41.29

2.7

ng/l

1027.0

1171.1

2.44

6582

32816

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

10899

55157

1.19

39.71

3.3

3.2

ng/l

29.5

56.4

1.64

6732

32886

(3015377) Calcium [Moles/volume] in Serum or Plasma

11036

56104

1.18

37.49

3.3

mmol/l

2.4

6.14

9447

49399

(3012516) Albumin [Mass/volume] in Urine

7991

39544

1.20

36.86

3.1

mg/l

518.1

485.4

0.19

4413

22449

(3044889) 12 lead EKG panel

20472

109441

1.17

36.33

3.6

3.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1500

11903

0.70

35.66

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2781

12257

1.32

35.64

3.3

3.2

ng/l

82.4

80.3

0.67

2329

10534

(3024561) Albumin [Mass/volume] in Serum or Plasma

12948

66931

1.17

34.94

4.1

4.3

g/l

36.0

35.8

2.78

11905

61970

(3050129) First trimester maternal screen panel - Serum or Plasma

346

3879

0.50

34.75

1.4

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

10164

51604

1.17

34.20

3.1

—

0.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

8356

41869

1.18

32.62

1.7

1.6

mmol/l

1.4

1.3

10.69

6917

35673

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

12305

63593

1.16

32.50

2.0

1.9

pmol/l

101.3

99.1

4.12

5720

31086

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3137

14219

1.28

32.44

3.1

3.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

15072

79104

1.15

32.18

5.3

5.1

estimate

0.0

1.34

2864

14198

(3009261) Glucose [Presence] in Urine by Test strip

15205

79876

1.15

31.96

4.0

3.8

estimate

0.0

0.15

2853

14230

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

3463

15961

1.26

31.16

3.4

3.7

ug/l

19.8

22.3

0.19

2634

12442

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

9704

49399

1.17

30.74

2.4

u/l

56.8

57.9

0.63

8834

45578

(4281824)

690

2393

1.65

30.48

1.1

—

(4035726)

3148

14429

1.27

29.59

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

8394

42420

1.17

28.75

3.0

mmol/l

6.6

0.25

6878

35834

(3018095) Leukocytes [#/volume] in Urine

10261

52730

1.16

28.00

3.5

e6/l

105.5

105.4

0.00

7036

35655

(42870588) Differential panel, method unspecified - Blood

10241

52630

1.16

27.90

5.6

5.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

7551

37970

1.17

27.26

2.3

2.2

umol/l

3525.1

3986.8

0.51

6408

33015

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

253

2894

0.49

27.09

1.3

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

14883

78597

1.14

27.09

3.9

3.8

estimate

0.0

0.20

2836

14010

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

318

3362

0.53

26.50

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

298

3203

0.52

26.24

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

298

3201

0.53

26.19

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

297

3190

0.53

26.09

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

297

3179

0.53

25.80

1.3

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

7886

39938

1.16

25.69

2.9

e6/l

0.4

0.94

5839

29541

(3002582) Erythrocytes [#/volume] in Urine

8497

43342

1.16

25.00

3.0

e6/l

112.2

59.0

1.49

6388

32405

(40761536) Microorganisms panel - Urine sediment

2779

12830

1.25

24.35

4.2

4.0

—

(3033658) Prothrombin time (PT) actual/Normal

7593

38471

1.16

24.35

3.4

3.5

96.9

95.6

4.48

7373

37365

(3026008) Bacteria identified in Urine by Culture

10156

52580

1.14

23.92

3.3

3.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

8870

45531

1.15

23.59

2.0

u/l

147.8

161.9

1.24

8267

42617

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

13926

73681

1.13

23.14

2.3

nmol/l

6705.4

78.8

0.50

12375

67176

(3047352) Trisomy 18 risk [Likelihood] in Fetus

246

2694

0.52

23.07

1.3

1.4

—

(3005033) Fetal Nuchal fold Thickness US

245

2685

0.52

23.03

1.3

1.4

—

(36304419) Bacteria [Presence] in Urine

7741

39409

1.15

23.02

2.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

257

2770

0.52

22.89

1.4

1.5

—

(3026782) Osmolality of Urine

5577

27791

1.17

21.84

2.7

2.6

mosm/kgh2o

509.8

504.8

0.76

4710

23483

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

355

1132

1.79

21.26

6.2

6.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

14362

76392

1.12

21.09

5.8

6.0

28.9

0.04

13232

71305

(3022145) Colonoscopy Study observation

3667

17685

1.20

20.93

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

17195

92517

1.12

20.39

8.5

8.9

e9/l

4.0

3.9

0.18

14916

81318

(3019069) Monocytes/100 leukocytes in Blood

13981

74376

1.12

20.11

6.0

6.2

8.2

8.3

1.25

12962

69805

(3015736) pH of Urine

11603

61069

1.12

20.03

3.6

5.9

5.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1073

4466

1.38

19.92

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

19570

106160

1.12

19.80

3.1

2.9

u/l

42.7

41.5

1.11

18147

99683

(3006504) Eosinophils/100 leukocytes in Blood

13905

74021

1.12

19.56

5.7

5.9

2.8

0.38

12810

69027

(3041096) Erythrocytes [Presence] in Urine by Automated

8221

42443

1.14

19.22

3.6

3.4

—

(3018010) Neutrophils/100 leukocytes in Blood

14137

75377

1.12

19.19

5.6

5.8

56.8

56.7

0.34

13074

70608

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1310

9671

0.76

19.08

1.4

—

(40768797) Stomach Pathology biopsy report

4663

23131

1.17

19.07

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3736

24652

0.84

18.96

1.7

—

(3018418) pH of Serum or Plasma

9165

47704

1.13

18.70

4.0

3.7

7.4

0.56

1727

8733

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

235

2436

0.55

18.45

1.7

—

(3021589) Normoblasts [#/volume] in Blood

13071

69569

1.11

17.85

9.2

8.9

e9/l

0.0

0.79

10652

57043

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

7409

38171

1.13

17.62

2.3

2.2

mg/l

3.1

2.9

7.27

6256

32885

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

160

413

2.21

17.31

2.3

3.2

ng/l

74.4

100.4

0.51

138

(3022096) Basophils/100 leukocytes in Blood

13441

71757

1.11

17.06

5.8

5.9

0.7

1.89

12375

66918

(3000850) Epithelial cells [#/volume] in Urine

5918

30118

1.14

16.86

2.5

e6/l

7.3

7.7

0.79

5083

26187

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

7134

36756

1.13

16.82

1.7

mg/l

1.0

0.04

5379

28103

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2958

14305

1.19

16.19

4.0

3.9

u/l

242.3

243.2

0.11

2764

13455

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

484

1803

1.53

16.12

2.0

2.1

mg/l

25.7

25.6

0.02

147

468

(3021960) Folate [Moles/volume] in Serum or Plasma

6748

34737

1.13

16.01

1.5

nmol/l

21.5

0.18

5582

29949

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

11463

60826

1.11

15.99

4.1

4.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4483

22467

1.16

15.78

2.6

2.7

e6/l

4.6

4.9

0.52

2333

11578

(3023368) Bacteria identified in Blood by Culture

6913

35721

1.13

15.33

3.9

—

(3013115) Eosinophils [#/volume] in Blood

15284

82452

1.10

15.04

5.7

5.9

e9/l

0.2

0.73

13380

73079

(3000764) Benzodiazepines [Presence] in Urine

573

4607

0.70

14.67

1.3

1.9

—

(3027944) Amphetamines [Presence] in Urine

566

4558

0.70

14.62

1.3

1.8

—

(3028300) Cannabinoids [Presence] in Urine

579

4640

0.70

14.54

1.3

1.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

5437

27760

1.14

14.50

1.8

1.7

nmol/l

1184.1

1195.6

0.37

3949

21248

(3016879) Cocaine [Presence] in Urine

514

4199

0.69

14.41

1.3

2.0

—

(40768793) Breast Pathology biopsy report

1306

5869

1.28

14.29

1.3

—

(3027008) Opiates [Presence] in Urine

580

4626

0.71

14.18

1.3

1.8

—

(3019198) Lymphocytes [#/volume] in Blood

15111

81632

1.10

14.04

5.6

5.8

e9/l

2.0

1.9

1.18

13275

72529

(3001604) Monocytes [#/volume] in Blood

14702

79382

1.10

13.66

5.5

5.8

e9/l

0.5

0.15

12649

69335

(3006315) Basophils [#/volume] in Blood

14763

79732

1.10

13.63

5.6

5.8

e9/l

0.0

0.94

12677

69566

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4671

23701

1.14

13.62

2.9

3.0

mmol/l

0.8

0.36

4294

21953

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6425

33280

1.12

13.42

1.7

1.6

pmol/l

28755245.0

39262560.4

0.77

5220

27836

(3049717) Cytology report of Urine Cyto stain

818

3485

1.34

13.23

2.3

2.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

4561

23191

1.14

12.82

2.3

umol/l

13.1

0.27

4160

21389

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3330

21543

0.87

12.71

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

6441

33464

1.12

12.66

1.3

iu/ml

28.4

35.8

2.50

2076

10957

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

191

1879

0.58

12.58

1.3

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

457

1781

1.47

12.40

5.2

4.3

u/ml

122.1

114.1

0.08

145

523

(3001122) Ferritin [Mass/volume] in Serum or Plasma

13818

74636

1.09

12.20

2.9

2.8

ug/l

97.5

94.7

0.74

12735

69781

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1151

0.47

12.11

1.1

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1780

8439

1.21

12.02

2.5

2.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4824

24726

1.13

11.87

2.5

e6/l

1.4

0.15

2671

13696

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5786

29993

1.12

11.73

2.7

2.8

mmol/l

2.5

5.55

5066

26137

(1001926) Buprenorphine [Presence] in Urine by Screen method

429

3482

0.70

11.69

1.3

2.0

—

(3009343) pH of Capillary blood

1570

7381

1.22

11.55

3.1

3.2

7.4

0.04

222

983

(3022313) Gas panel - Capillary blood

1138

5187

1.26

11.15

3.2

3.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

6140

32015

1.11

11.12

1.3

u/ml

8.3

12.1

5.22

2347

12968

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

934

0.44

11.07

1.3

1.5

mmol/l

8.8

7.8

1.47

581

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2587

12767

1.17

11.02

3.6

3.3

mmol/l

1.2

0.81

2214

11150

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1582

7481

1.21

10.99

3.1

3.2

kpa

5.2

0.09

1453

6891

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1508

7110

1.22

10.80

3.1

3.2

mmol/l

2.1

2.0

0.73

1140

5354

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

852

0.43

10.77

16.7

15.9

nmol/l

1431.9

5329.1

1.04

809

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2780

13840

1.16

10.54

2.1

g/l

0.2

3.22

2607

12936

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1008

4568

1.26

10.40

3.3

3.4

mmol/l

25.2

25.1

0.94

918

4191

(3027456) Digoxin [Moles/volume] in Serum or Plasma

592

2508

1.35

10.06

3.3

nmol/l

0.8

0.25

454

1984

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3684

18767

1.13

9.92

6.3

6.5

—

(3042936) Bacteria identified in Isolate by Culture

3884

19858

1.13

9.85

1.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

6281

32974

1.10

9.82

1.4

g/l

2.2

2.3

3.24

3649

19862

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

452

1849

1.40

9.55

1.5

1.4

ug/l

4.9

3.3

0.58

333

1477

(3024522) Salmonella sp identified in Specimen by Organism specific culture

487

2024

1.37

9.38

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

496

2068

1.37

9.36

1.4

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

561

2394

1.34

9.13

1.3

1.2

nmol/l

0.6

1.6

1.03

534

2311

(3025468) Yersinia sp identified in Specimen by Organism specific culture

479

1997

1.37

9.06

1.4

—

(40768443) Skin Pathology biopsy report

1513

7259

1.19

9.06

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1228

5780

1.22

9.00

1.9

—

(21494755) Public health laboratory ask at order entry panel

2565

16510

0.87

8.98

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9726

52245

1.08

8.94

3.1

u/l

30.5

31.7

1.30

9224

49609

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

482

2018

1.36

8.89

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

478

2003

1.36

8.78

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

481

2019

1.36

8.74

1.4

1.3

pmol/l

298.3

313.2

0.31

376

1591

(3048689) Calprotectin [Mass/mass] in Stool

4148

21431

1.12

8.73

2.1

ug/g

121.5

116.1

0.30

3196

16613

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

558

2397

1.33

8.71

1.3

1.2

nmol/l

0.4

0.2

1.07

140

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

816

3688

1.26

8.68

1.5

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

515

2190

1.34

8.61

1.3

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

122

374

1.86

8.61

1.3

1.2

g/l

38.0

38.3

0.10

190

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3768

19381

1.12

8.58

2.4

21.7

22.1

0.91

3205

16493

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

476

2001

1.36

8.58

1.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2836

14339

1.14

8.57

2.4

1.8

0.37

2471

12632

(3003338) MCHC [Mass/volume]

23612

137207

0.92

8.56

17.6

16.6

g/l

330.3

330.7

9.86

23455

136205

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3494

17898

1.12

8.54

4.7

mmol/l

1.0

0.85

3190

16555

(4094501)

860

3919

1.25

8.54

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

7862

41933

1.09

8.51

4.4

4.3

estimate

0.0

0.60

2854

14148

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7382

39273

1.09

8.48

1.3

u/ml

1.4

1.5

0.61

1897

10982

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2432

15645

0.87

8.44

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2560

12880

1.14

8.34

3.5

3.3

pmol/l

4.5

4.4

0.32

2293

11453

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2379

11918

1.15

8.26

2.4

2.3

au/ml

23.3

25.9

0.40

104

801

(3021788) Differential panel - Synovial fluid

605

2653

1.30

8.19

1.6

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

623

2746

1.30

8.12

3.0

3.2

u/ml

971.5

581.1

0.33

554

2476

(3011288) Drugs identified in Urine by Screen method

403

3104

0.74

8.11

1.5

2.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4083

21166

1.11

8.05

2.3

g/l

2.4

1.96

3719

19471

(3000475) Leukocytes [#/volume] in Synovial fluid

777

3528

1.26

7.99

1.7

e6/l

8763.1

11102.8

1.21

570

2568

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

662

0.45

7.94

1.5

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3477

17887

1.12

7.88

2.3

2.5

umol/l

6.5

7.3

1.67

2954

15128

(3045424) Erythrocytes [Presence] in Urine

615

2720

1.29

7.83

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2141

13820

0.87

7.82

1.7

—

(3017732) Neutrophils [#/volume] in Blood

2307

11580

1.14

7.79

2.8

2.7

e9/l

3.9

4.0

0.71

1731

9160

(3023520) Reticulocytes [#/volume] in Blood

2090

10438

1.15

7.60

2.5

2.4

e9/l

71.1

70.8

0.11

1566

7742

(3022217) INR in Platelet poor plasma by Coagulation assay

3392

17463

1.12

7.58

23.6

20.2

inr

1.3

1.2

0.75

490

2530

(3009542) Hematocrit [Volume Fraction] of Blood

26082

145764

1.09

7.58

14.7

13.9

39.1

0.13

18873

108752

(3013139) Helicobacter pylori Ag [Presence] in Stool

2466

12473

1.13

7.42

1.3

1.2

—

(3011985) Renin [Units/volume] in Plasma

504

2192

1.31

7.30

1.5

1.6

mu/l

52.0

53.1

0.05

458

1955

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1106

5264

1.20

7.30

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1816

9030

1.15

7.04

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

351

1457

1.37

6.95

1.0

—

(1761868) Lipid panel - Serum or Plasma

10809

58714

1.07

6.92

2.9

2.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

787

5456

0.82

6.85

1.9

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

418

1790

1.33

6.78

1.6

50.9

53.0

0.47

264

1089

(3045414) Leukocytes [Presence] in Urine

1519

7491

1.16

6.61

1.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1383

6774

1.17

6.57

2.0

2.1

u/l

40.1

40.2

0.04

1222

6129

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2156

10910

1.13

6.46

1.3

au/ml

51.8

47.3

0.31

488

(3011397) Hemoglobin [Presence] in Urine by Test strip

7029

37676

1.08

6.46

3.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

985

4697

1.20

6.42

1.4

ug/g

290.7

285.7

0.31

543

2665

(4024509)

369

1567

1.34

6.37

1.7

1.6

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

373

1592

1.34

6.23

3.9

3.0

nmol/l

5.6

8.0

0.31

362

1531

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

812

0.56

6.19

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3943

20676

1.10

6.12

2.0

29.4

29.3

0.67

3826

20010

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

751

3507

1.22

6.09

1.4

1.3

—

(4146454)

320

1343

1.36

5.99

2.7

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

135

478

1.61

5.92

1.5

1.6

ug/l

0.4

0.32

322

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4242

22361

1.09

5.85

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1380

8984

0.87

5.76

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2583

16181

0.90

5.73

1.3

1.4

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

859

4093

1.20

5.70

2.1

2.4

g/l

3.5

3.6

1.44

806

3878

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1582

7926

1.14

5.57

1.6

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

158

2.05

5.50

2.3

2.7

pmol/l

104.5

51.4

0.65

132

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

261

1077

1.38

5.47

3.9

2.8

nmol/l

187.9

108.2

1.55

256

1057

(40758558) Short blood count panel - Blood

7650

41353

1.07

5.41

6.3

6.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

225

908

1.41

5.37

1.9

1.6

mmol/24h

6.6

5.1

0.59

(3042301) Urate [Moles/volume] in Synovial fluid

4.33

5.36

1.0

umol/l

315.3

372.2

—

(3044927) Protein electrophoresis panel - Urine

290

1224

1.35

5.29

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

539

2471

1.24

5.26

1.5

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

23890

133588

1.06

5.19

16.3

15.5

13.7

4.06

23439

130841

(3008757) Leukocyte morphology finding [Identifier] in Blood

324

1395

1.32

5.19

3.6

3.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

895

4321

1.18

5.16

2.1

2.2

mg/l

10.6

0.01

820

4033

(3003327) Ova and parasites identified in Stool by Light microscopy

1193

5898

1.16

5.11

1.8

1.7

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

437

1964

1.27

5.08

1.4

1.3

nmol/l

41.3

23.6

—

(3000330) Specific gravity of Urine by Test strip

1505

7570

1.14

5.02

3.7

3.5

—

(3028707) Methadone [Presence] in Urine by Screen method

264

2004

0.75

5.01

1.4

2.5

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

107

954

0.64

5.00

10.7

12.0

mmol/l

0.6

0.00

870

(3037522) Nuclear Ab [Titer] in Serum

4694

25004

1.08

4.99

1.4

titre

502.7

604.0

3.44

1032

5468

(3009466) Valproate [Moles/volume] in Serum or Plasma

279

2099

0.75

4.97

5.3

5.2

umol/l

374.2

377.9

0.16

238

1837

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

391

1739

1.28

4.95

1.2

u/l

36.7

31.7

0.27

340

1514

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

5251

28099

1.07

4.94

3.4

ng/l

253.6

277.2

0.22

3703

19645

(3004588) Protein electrophoresis panel - Serum or Plasma

1800

9166

1.12

4.93

2.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

915

4449

1.17

4.87

3.6

3.5

u/ml

37.2

37.4

0.01

886

4290

(3005719) IgG [Mass/volume] in Serum or Plasma

2269

11723

1.11

4.79

2.7

g/l

10.1

10.4

2.11

2044

10759

(3010144) Erythrocytes [#/volume] in Synovial fluid

303

1314

1.31

4.66

1.4

1.5

e6/l

110326.4

88802.2

0.22

188

910

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2792

14596

1.10

4.64

2.3

2.4

u/l

37.7

37.2

0.07

2388

12407

(4010399)

2219

11473

1.11

4.63

1.4

—

(3014271) Vancomycin [Susceptibility]

162

635

1.45

4.59

2.7

3.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1772

9055

1.12

4.59

1.7

1.8

g/l

1.3

1.4

1.01

1605

8256

(3000494) Fungus identified in Specimen by Culture

3439

18155

1.09

4.58

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1502

7607

1.13

4.53

5.7

6.2

mmol/l

25.0

0.09

1488

7535

(3007853) Bacteria identified in Skin by Aerobe culture

3365

17758

1.09

4.52

1.7

—

(3025941) Bacteria identified in Stool by Culture

1916

9846

1.11

4.49

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

138

1.98

4.29

1.3

mmol/l

6.2

5.3

0.68

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

342

1527

1.28

4.27

1.1

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2951

15526

1.09

4.27

2.1

nmol/l

371.9

374.3

0.25

2679

14266

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

693

3337

1.18

4.21

2.5

2.4

—

(3044941) Cell count panel - Synovial fluid

489

2281

1.22

4.16

1.4

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

787

3840

1.17

4.09

1.6

—

(1002224) Polysomnography panel

1323

6696

1.13

4.07

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2155

11209

1.10

4.02

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

877

4323

1.16

4.00

2.1

2.2

183.9

182.2

0.21

821

4062

(40762814) Titanium [Mass/volume] in Blood

208

1.75

3.99

2.3

2.2

ug/l

2.9

4.3

1.72

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

817

4007

1.16

3.98

3.4

3.2

mg/l

35.5

42.5

0.79

654

3259

(3034860) Kappa light chains.free [Mass/volume] in Serum

819

4023

1.16

3.92

3.4

3.2

mg/l

40.9

79.2

1.21

660

3276

(3028271) Lactate [Moles/volume] in Capillary blood

443

2061

1.23

3.90

1.7

1.8

mmol/l

1.6

1.7

1.97

433

2013

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

141

560

1.43

3.81

2.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

791

3891

1.16

3.74

3.3

3.1

ratio

1.8

2.4

0.40

321

(3020650) Glucose [Presence] in Urine

100

372

1.53

3.73

1.4

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

415

1930

1.23

3.69

1.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

367

1685

1.24

3.68

1.9

2.0

u/ml

31.2

1035.8

1.06

355

1625

(3037121) Protein [Mass/volume] in Urine

949

4736

1.14

3.67

2.6

2.9

g/l

0.3

0.27

307

1634

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1099

5538

1.13

3.67

1.7

g/l

1.6

0.08

928

4722

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

988

4945

1.14

3.66

1.9

iu/l

4.5

13.5

1.14

381

1903

(3020630) Protein [Mass/volume] in Serum or Plasma

2143

11198

1.09

3.65

2.6

2.5

g/l

66.3

66.6

0.86

1889

10097

(1761482) Bacteria [#/volume] in Urine by Culture

734

3598

1.16

3.64

4.7

4.5

—

(3036603) Volume of Urine

230

999

1.31

3.61

1.5

1776.6

1920.4

0.62

218

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

259

1145

1.29

3.57

2.9

2.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

472

3209

0.83

3.56

1.2

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

879

5692

0.87

3.54

1.3

miu/ml

216.5

222.7

0.20

406

2813

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.47

3.47

1.3

u/field

1.0

1.2

0.64

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

325

1485

1.25

3.43

5.6

6.1

mg/l

12.0

12.1

0.08

294

1360

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1332

6826

1.11

3.38

1.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1013

5109

1.13

3.37

1.3

u/ml

7.8

7.2

0.09

182

861

(3002179) Metamyelocytes/100 leukocytes in Blood

2221

11670

1.09

3.36

3.8

0.7

0.12

488

2317

(3010421) pH of Blood

705

3474

1.16

3.30

2.9

3.3

7.4

0.11

588

2865

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

255

1139

1.28

3.28

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1102

5598

1.12

3.27

1.3

u/ml

28.6

38.6

0.61

384

(3012501) Base excess in Blood by calculation

602

2936

1.17

3.24

3.0

3.5

mmol/l

2.5

2.7

0.84

431

2036

(3013290) Carbon dioxide [Partial pressure] in Blood

602

2937

1.17

3.22

3.0

3.5

kpa

5.0

0.02

588

2866

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

253

1132

1.27

3.22

1.3

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

995

5032

1.13

3.19

1.3

u/ml

3.4

6.4

1.39

126

542

(3027315) Oxygen [Partial pressure] in Blood

606

2961

1.17

3.19

3.1

3.5

kpa

8.6

8.7

0.19

592

2890

(3025577) Chromium [Mass/volume] in Blood

165

697

1.35

3.18

2.1

ug/l

2.4

2.9

0.80

140

595

(3034274) Bile acid [Moles/volume] in Serum --fasting

254

1815

0.79

3.17

1.6

1.9

umol/l

6.8

6.6

0.06

184

1303

(3004809) Band form neutrophils/100 leukocytes in Blood

452

2156

1.19

3.16

3.1

3.0

1.1

1.5

3.29

367

1673

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1034

5246

1.12

3.15

2.8

3.3

u/ml

6590.3

1068.0

0.44

861

4393

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

18731

108384

0.96

3.15

3.0

3.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

259

1167

1.26

3.12

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

140

578

1.38

3.12

1.1

98.7

95.8

0.37

249

(3045142) Bone marrow Pathology biopsy report

289

1320

1.25

3.11

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

130

1009

0.73

3.04

1.3

mmol/l

5.9

5.7

1.82

122

944

(3005322) IgE [Units/volume] in Serum or Plasma

2189

11554

1.08

3.00

1.3

u/ml

139.1

190.3

2.70

2028

10695

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

853

4292

1.13

2.99

1.3

u/ml

43.5

43.3

0.01

106

462

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

187

813

1.31

2.99

1.6

1.7

130.0

135.1

0.42

177

760

(3026470) Cobalt [Mass/volume] in Blood

168

721

1.33

2.95

2.1

2.0

ug/l

3.3

4.2

1.01

152

639

(40767503) Oxygen content in Capillary blood by calculation

561

2744

1.17

2.95

2.4

16.1

16.2

0.05

281

1353

(40760888) Immunoglobulin light chains.free panel - Serum

608

2995

1.16

2.91

3.4

3.3

—

(40768441) Liver Pathology biopsy report

252

1143

1.26

2.91

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

274

1.54

2.90

1.1

pmol/l

23.7

3.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

757

3788

1.14

2.90

2.8

2.9

u/ml

0.4

0.57

443

2165

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

181

1.67

2.88

1.1

1.0

—

(3012565) Volume of 24 hour Urine

166

714

1.32

2.88

2.1

1.9

1842.0

1946.9

0.81

150

641

(3027923) C peptide [Moles/volume] in Serum or Plasma

161

692

1.32

2.81

1.4

1.7

nmol/l

1.2

1.3

0.42

119

561

(3021440) Promyelocytes/100 leukocytes in Blood

2309

12248

1.08

2.81

4.1

4.0

0.2

0.1

0.30

621

2975

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

256

1799

0.81

2.80

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

407

1948

1.19

2.79

2.3

2.4

u/ml

3366.6

1240.0

0.28

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

590

2911

1.16

2.79

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

142

600

1.35

2.78

1.1

113.7

115.3

0.22

125

540

(3017181) Myelocytes/100 leukocytes in Blood

2416

12849

1.07

2.74

4.0

1.1

0.9

1.27

667

3236

(3000012) Reticulocyte production index

161

695

1.32

2.74

1.5

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

589

2910

1.15

2.74

1.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

774

3898

1.13

2.72

1.6

1.4

iu/ml

22.8

15.3

0.65

107

(40761539) Cells [Type] in Urine sediment by Light microscopy

331

1.46

2.66

1.2

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

125

1.78

2.66

4.1

2.4

pmol/l

36.4

67.6

0.46

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

905

4613

1.12

2.61

1.9

2.0

95.9

95.8

0.05

826

4232

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

138

589

1.33

2.57

1.1

92.4

93.7

0.21

252

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1343

6995

1.10

2.56

2.6

2.4

e6/l

0.3

0.11

1289

6708

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

625

3119

1.14

2.55

1.3

1.4

nmol/l

0.4

0.22

454

2300

(3014133) Dog dander IgE Ab [Units/volume] in Serum

365

2451

0.85

2.51

1.0

1.1

u/ml

4.3

3.9

0.12

123

849

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

339

2285

0.84

2.45

1.3

mmol/l

7.4

7.2

0.48

242

1691

(3022621) pH of Urine by Test strip

2007

10656

1.08

2.42

3.2

3.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.51

2.39

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

160

1.64

2.39

1.0

1.1

u/ml

6.2

3.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

419

2767

0.86

2.36

1.1

u/ml

1.7

1.6

0.05

613

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

134

578

1.32

2.35

1.6

1.7

144.5

155.3

0.82

126

538

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

988

5094

1.11

2.35

1.4

—

(3036489) Thrombin time

1096

5681

1.10

2.34

1.7

1.9

21.5

21.1

0.72

930

4858

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

170

1.61

2.33

5.2

5.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

281

1326

1.21

2.32

3.0

56.0

58.8

1.07

199

846

(3028433) Virus identified in Specimen by Culture

111

469

1.35

2.25

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

400

1953

1.17

2.25

1.2

u/l

59.1

57.8

0.23

262

1334

(3025130) Human papilloma virus identified in Specimen

570

3670

0.88

2.25

1.6

1.7

—

(4198724)

500

0.68

2.24

1.2

2.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

157

0.43

2.23

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

816

4180

1.11

2.21

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

397

1943

1.16

2.18

1.1

iu/ml

33.3

6527.6

0.65

419

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

865

4450

1.11

2.17

2.2

2.3

g/l

0.6

0.7

0.68

714

3824

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1503

7930

1.08

2.17

1.3

u/ml

1.3

0.9

0.55

152

704

(3024263) Appearance of Synovial fluid

160

716

1.27

2.17

1.9

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

728

3714

1.12

2.14

2.3

2.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

153

682

1.28

2.14

1.1

1.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

6634

36530

1.04

2.14

4.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

453

0.68

2.11

1.9

2.4

nmol/l

150.0

164.2

0.52

405

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

322

0.62

2.10

2.0

1.9

umol/l

17.0

17.3

0.05

322

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2744

16444

0.94

2.10

1.5

1.6

1.3

1.4

0.31

2423

14556

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

344

1.39

2.09

1.1

92.0

0.00

(3032868) Hemoglobin electrophoresis panel in Blood

1.81

2.09

1.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

599

0.72

2.08

1.1

1.2

—

(3025159) Blasts/100 leukocytes in Blood

2180

11680

1.07

2.06

4.1

0.3

0.2

0.21

539

2540

(3006922) Hepatitis E virus Ab [Presence] in Serum

224

1048

1.22

2.06

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

961

4993

1.10

2.01

1.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

338

1.38

1.98

1.7

1.9

u/l

26.5

38.2

0.47

301

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

287

1.41

1.92

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

152

1.57

1.92

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

764

3935

1.11

1.92

1.2

u/ml

23.3

9.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

350

1.37

1.91

1.8

1.6

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

616

3138

1.12

1.90

3.0

3.2

e9/l

4.0

0.04

616

3131

(3004616) Nuclear Ab [Presence] in Serum

461

2307

1.14

1.90

1.3

1.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.61

1.90

2.8

3.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

232

1100

1.20

1.89

1.7

1.9

mg/l

3.0

3.6

1.79

215

1056

(3024980) IgG subclass 4 [Mass/volume] in Serum

505

2544

1.13

1.88

1.5

g/l

0.6

0.02

367

1945

(3028626) Oxygen [Partial pressure] in Capillary blood

512

2584

1.13

1.86

2.7

2.6

kpa

8.3

0.19

474

2397

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1181

6218

1.08

1.85

1.5

u/ml

12.3

14.6

0.29

149

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

1.87

1.83

1.6

9.4

15.5

—

(3032057) Clostridioides difficile [Presence] in Stool

329

1.37

1.82

1.7

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

968

5058

1.09

1.82

1.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

257

1.42

1.82

2.0

2.4

mmol/l

6.7

7.0

0.36

152

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

895

4661

1.09

1.81

1.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

187

873

1.22

1.80

1.5

1.8

102.1

0.00

169

796

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.70

1.80

1.1

1.0

u/ml

0.0

0.1

—

(3021901) Oxygen saturation in Capillary blood

435

2178

1.14

1.80

2.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

967

5056

1.09

1.80

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

794

4116

1.10

1.78

2.1

g/l

37.7

38.0

0.64

652

3495

(3027874) Urate [Moles/volume] in Urine

2.50

1.77

1.1

1.0

mmol/l

0.8

1.9

—

(3008037) Lactate [Moles/volume] in Venous blood

566

2884

1.12

1.77

2.9

3.0

mmol/l

1.5

0.14

554

2833

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

239

1146

1.19

1.75

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1930

10363

1.06

1.75

6.7

6.4

mmol/l

9.0

8.9

0.18

1825

9863

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.74

1.75

1.1

1.0

u/ml

0.0

0.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

1796

9625

1.06

1.73

3.1

2.9

kpa

4.5

0.07

1746

9322

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

229

1095

1.19

1.73

2.0

1.9

nmol/l

16.8

17.3

0.53

223

1033

(3006270) Folate [Moles/volume] in Blood

286

1394

1.17

1.73

1.2

1.1

nmol/l

376.0

375.4

0.02

250

1200

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

347

1.34

1.73

1.1

75.5

76.8

0.06

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

166

1.51

1.72

3.1

2.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1227

6493

1.08

1.71

7.6

8.4

mmol/l

24.5

0.11

1136

6066

(3003888) Timothy IgE Ab [Units/volume] in Serum

473

3020

0.89

1.71

1.1

u/ml

2.5

3.6

1.65

193

1414

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

339

0.67

1.71

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

233

1118

1.19

1.70

1.5

1.3

nmol/l

1.6

1.5

1.00

208

1011

(3040151) Glucose [Moles/volume] in Capillary blood

294

1439

1.16

1.69

3.9

7.4

mmol/l

7.5

7.3

0.25

242

1176

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

787

4091

1.10

1.68

2.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

121

543

1.27

1.68

2.0

1.7

—

(40768446) Kidney Pathology biopsy report

428

1.30

1.68

1.7

1.6

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.73

1.67

1.1

1.0

u/field

1.6

1.3

0.42

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.68

1.67

2.1

2.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

335

1.34

1.65

1.2

—

(3038515) Glucose [Moles/volume] in Venous blood

533

2719

1.12

1.65

3.0

3.1

mmol/l

7.4

0.12

523

2672

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

697

4349

0.91

1.65

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

423

0.71

1.64

1.0

1.1

—

(21494434) Karyotype in Bone marrow

211

1008

1.19

1.64

1.2

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2095

11308

1.06

1.61

5.9

6.2

mmol/l

1.3

0.04

2025

10935

(40768795) Lymph node Pathology biopsy report

340

1690

1.15

1.61

1.2

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.73

1.60

1.3

1.7

umol/l

0.8

0.21

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.73

1.60

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

532

0.75

1.59

1.1

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

451

2872

0.89

1.59

1.1

u/ml

0.8

0.05

155

1098

(3020717) Zinc [Moles/volume] in Serum or Plasma

193

919

1.20

1.57

1.3

1.4

umol/l

28.2

26.3

0.33

181

869

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.69

1.56

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

462

2348

1.12

1.55

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

135

0.51

1.55

1.1

1.0

u/ml

0.1

0.2

—

(3047189) Immunofixation for 24 hour Urine

110

494

1.27

1.55

1.8

1.9

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

359

1.32

1.54

1.3

1.4

43.8

41.0

0.25

240

(3042631) Mycobacterium sp identified in Specimen

334

1664

1.14

1.54

2.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

995

5249

1.08

1.54

2.2

g/l

3.7

0.17

685

3727

(3047007) Chlamydophila sp Ab [Presence] in Serum

507

2592

1.11

1.54

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

998

5266

1.08

1.54

2.2

g/l

7.6

7.4

1.81

724

3920

(3021387) Prolactin [Units/volume] in Serum or Plasma

861

5301

0.92

1.53

1.7

mu/l

321.1

338.9

0.56

774

4735

(3051387) C reactive protein [Mass/volume] in Capillary blood

619

3199

1.10

1.53

3.8

3.4

mg/l

22.6

24.0

0.40

378

1968

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

996

5257

1.08

1.52

2.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.72

1.52

1.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

429

2174

1.12

1.52

1.6

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.56

1.51

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

123

562

1.25

1.50

2.2

2.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

946

4987

1.08

1.50

2.2

g/l

3.1

0.40

700

3832

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.04

1.50

1.1

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

344

1722

1.14

1.49

1.6

1.7

90.2

90.1

0.19

338

1696

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

133

0.51

1.49

1.0

1.1

mg/l

42.7

43.7

—

(3016244) Insulin [Units/volume] in Serum or Plasma

218

1056

1.18

1.47

3.2

3.4

mu/l

27.8

28.0

0.02

205

1013

(3037756) Immunofixation for Serum or Plasma

518

2659

1.11

1.47

1.7

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.78

1.47

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

3.55

1.47

1.0

1.1

nmol/24h

21.8

21.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

931

4910

1.08

1.47

2.1

2.2

g/l

9.9

10.1

0.69

744

4064

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

460

2909

0.90

1.46

1.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

359

2302

0.89

1.45

1.1

u/ml

3.5

0.00

125

870

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

146

0.55

1.44

1.4

1.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

117

535

1.24

1.43

2.0

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

117

535

1.24

1.43

2.0

1.7

—

(4212803)

109

1.57

1.42

1.1

1.0

—

(3018405) Lactate [Moles/volume] in Arterial blood

753

4644

0.92

1.42

4.1

3.8

mmol/l

1.3

0.18

740

4567

(3020876) Protein [Mass/time] in 24 hour Urine

204

987

1.18

1.41

2.0

1.9

g/24h

0.7

1.0

0.58

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

247

1214

1.16

1.41

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

987

6019

0.93

1.40

1.8

2.0

u/l

5292.0

4156.9

0.53

323

2334

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

502

2582

1.11

1.39

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

526

0.77

1.39

1.7

ug/l

8.8

8.7

0.07

526

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

411

1.27

1.38

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

193

932

1.18

1.38

1.2

1.1

u/l

24.1

21.7

0.24

153

721

(43055442) Apixaban [Mass/volume] in Serum or Plasma

161

1.45

1.37

1.6

1.4

ug/l

102.7

120.2

0.42

135

(3006184) Hemoglobin [Mass/volume] in Capillary blood

596

3095

1.10

1.37

2.2

2.1

g/l

129.0

127.6

0.74

413

2205

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

288

1864

0.88

1.37

1.4

1.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

537

2775

1.10

1.36

1.2

1.3

titre

101.8

96.2

0.08

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

197

954

1.18

1.36

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

138

1.48

1.36

1.1

—

(3012544) pH of Venous blood

2226

12099

1.05

1.36

3.7

3.4

7.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

352

1.29

1.35

1.2

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

157

1.45

1.35

1.8

2.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.16

1.35

1.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

192

929

1.18

1.34

1.2

1.1

u/l

80.6

80.8

0.01

157

742

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

269

1336

1.15

1.34

1.2

titre

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

227

0.65

1.34

1.2

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

587

3051

1.10

1.33

2.7

mmol/l

25.2

0.01

522

2670

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

779

4101

1.08

1.32

1.3

u/ml

5.6

6.2

0.07

326

(3033705) Calcium.ionized [Moles/volume] in Venous blood

318

1600

1.13

1.31

2.1

2.3

—

(36660697) Celiac disease serology panel - Serum

2589

14139

1.04

1.30

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1133

6051

1.07

1.30

2.9

2.7

1.2

1.3

0.85

1127

6017

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

208

1017

1.16

1.29

1.3

g/l

1.6

1.5

0.63

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

309

1982

0.89

1.29

1.0

u/ml

0.1

0.3

1.04

355

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

197

1.39

1.29

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

169

0.61

1.28

1.1

1.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

743

3911

1.08

1.27

1.3

1.4

u/l

32.2

33.6

0.50

618

3173

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

197

961

1.17

1.27

1.1

—

(1616796) Gas panel - Central venous blood

543

2821

1.10

1.26

3.1

3.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

925

4912

1.07

1.26

1.7

1.6

titre

298.2

277.7

0.08

241

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

303

1525

1.13

1.26

2.0

32.0

32.1

0.10

298

1515

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

236

1168

1.15

1.26

1.1

mg/l

299.2

562.5

0.51

212

1030

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

198

1.38

1.26

2.9

2.4

u/field

0.5

0.8

1.54

198

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

131

617

1.21

1.25

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

287

1440

1.13

1.25

1.2

u/ml

77.2

65.0

0.30

(3032773) Endomysium IgG Ab [Titer] in Serum

301

1515

1.13

1.25

1.1

titre

—

54.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

661

4072

0.92

1.25

4.3

4.1

mmol/l

3.8

0.29

627

3838

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

237

1174

1.15

1.25

1.9

ug/l

20.7

25.0

0.59

230

1151

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

180

873

1.17

1.25

1.1

u/ml

9.2

6.7

0.48

139

(3035320) C reactive protein [Mass/volume] in Body fluid

239

1185

1.15

1.24

2.3

2.4

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.27

1.23

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

408

1.26

1.23

1.3

2.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

197

964

1.16

1.23

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

287

1443

1.13

1.22

1.2

u/ml

40.4

46.5

0.19

128

(3003157) Bacteria [#/volume] in Mother's milk

0.00

1.22

0.0

6.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.56

1.20

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

168

814

1.17

1.19

1.8

1.6

nmol/l

2.5

9.7

0.57

148

661

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

493

2559

1.10

1.19

2.1

2.0

nmol/l

0.9

0.8

0.72

407

2152

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.54

1.18

3.0

2.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1439

7769

1.06

1.18

3.2

3.1

g/l

127.8

126.8

1.06

1405

7590

(3014576) Chloride [Moles/volume] in Serum or Plasma

3012

16542

1.04

1.17

6.1

6.3

mmol/l

104.4

104.2

1.13

2960

16190

(3010370) Gastrin [Moles/volume] in Serum or Plasma

245

1.32

1.17

1.8

pmol/l

55.7

60.1

0.08

207

(40761535) Cells panel - Urine sediment

2289

12503

1.04

1.16

3.6

3.7

—

(40768806) Pleura Pathology biopsy report

213

1054

1.15

1.16

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

486

0.78

1.16

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

134

1.44

1.16

2.6

mg/l

0.9

1.3

1.24

(3038026) Centromere Ab [Units/volume] in Serum

293

1482

1.13

1.15

1.3

u/ml

30.9

59.1

1.00

(4015189)

346

1.27

1.15

2.1

2.5

—

(3024928) Oxygen saturation in Venous blood

489

2543

1.09

1.14

3.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2014

10976

1.05

1.14

2.1

2.2

ug/l

5.6

0.00

1643

9385

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

111

1.49

1.14

3.0

2.7

mmol/l

0.5

1.0

1.97

(3004446) Plasmodium sp identified in Blood by Light microscopy

163

0.63

1.13

2.4

2.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

222

1.33

1.13

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

145

699

1.18

1.11

1.4

—

(4211845)

170

831

1.16

1.10

4.1

3.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

145

700

1.18

1.10

1.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

238

1.31

1.10

1.6

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

155

753

1.17

1.09

1.1

1.0

96.2

95.8

0.05

117

589

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

199

1.34

1.08

1.2

ng/l

47.6

65.1

0.61

119

(3012441) Differential panel - Pleural fluid

205

1018

1.15

1.08

1.5

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

160

780

1.17

1.08

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

195

0.67

1.08

18.4

7.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

587

0.81

1.07

1.2

g/l

0.3

0.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

541

3329

0.92

1.05

1.1

u/ml

1.4

1.2

0.16

178

1191

(40765089) Chromosome analysis panel - Blood by G-banded

227

0.70

1.04

1.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1105

5947

1.06

1.04

2.8

2.7

0.7

0.63

1068

5682

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2144

11730

1.04

3.7

3.4

kpa

5.8

0.84

2091

11388

(1617658) Protocol used for examination of sentinel lymph nodes

399

2067

1.10

1.04

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.52

1.03

2.1

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.58

1.03

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

117

0.58

1.03

9.3

6.7

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

206

1.33

1.03

1.9

3.1

u/l

243.7

2032.4

1.63

193

(3007566) Smooth muscle Ab [Titer] in Serum

848

4530

1.07

1.03

1.2

titre

128.0

147.5

0.29

387

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.52

1.02

1.2

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.52

1.02

1.6

1.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.71

1.02

1.3

1.5

nmol/l

543.3

392.8

0.61

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

196

976

1.14

1.01

1.3

1.5

u/l

5.5

5.3

0.24

165

807

(3007919) Fasciola sp Ab [Titer] in Serum

2.10

1.01

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

270

1373

1.12

1.01

1.5

1.6

42.4

33.9

2.73

161

809

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

190

946

1.14

0.99

1.3

1.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.53

0.99

4.5

4.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

313

1.25

0.99

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

138

671

1.17

0.99

1.2

u/l

11.3

11.7

0.16

125

609

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

204

0.70

0.98

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

144

1.38

0.98

1.9

2.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

143

0.64

0.98

4.4

6.9

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

228

1151

1.13

0.97

1.6

u/l

6.8

6.1

0.18

569

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

386

1.22

0.96

1.2

pmol/l

370.4

325.9

0.42

286

(3003129) Base excess in Capillary blood by calculation

294

1.26

0.96

1.8

1.7

mmol/l

0.9

1.1

0.12

280

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1079

5821

1.06

0.96

4.4

3.8

mmol/l

24.4

0.05

990

5197

(3023199) Leukocytes [#/volume] in Pleural fluid

246

1249

1.12

0.96

1.4

e6/l

2052.3

3377.4

1.08

181

912

(3017509) Phencyclidine [Presence] in Urine

142

0.64

0.95

1.3

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

271

1384

1.11

0.95

1.2

u/ml

2.4

8.6

2.05

120

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

597

0.83

0.95

1.2

2.0

—

(3002032) Base excess in Venous blood by calculation

2133

11697

1.04

0.94

3.7

3.4

mmol/l

2.1

0.03

1790

9684

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

222

0.72

0.94

18.8

7.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

570

3015

1.08

0.94

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

326

1683

1.10

0.94

1.5

—

(37021550) Renin [Units/volume] in Plasma --upright

336

1.24

0.94

1.3

mu/l

64.8

70.3

0.12

255

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

152

749

1.15

0.93

1.4

u/l

12.4

12.2

0.13

145

723

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

686

3654

1.07

0.93

2.2

g/l

0.0

1.23

611

3314

(3006462) Nitrate [Presence] in Urine

155

765

1.15

0.93

4.2

3.1

—

(3013862) HLA-DP [Type]

1.63

0.93

1.1

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1781

9735

1.04

0.93

1.6

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

219

1107

1.13

0.93

1.3

1.2

u/l

19.6

22.2

0.37

187

956

(3034770) Mitochondria Ab [Titer] in Serum

848

4551

1.06

0.92

1.2

titre

800.0

980.5

0.38

196

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2283

12548

1.04

0.91

2.4

2.6

ml/min/173m2

68.6

66.5

1.25

907

5076

(3028308) Erythrocytes [#/volume] in Pleural fluid

221

1120

1.12

0.90

1.4

e6/l

50918.5

39152.8

0.27

129

643

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

191

1.31

0.90

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

132

646

1.16

0.90

1.6

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

186

933

1.13

0.90

1.3

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

180

901

1.14

0.90

1.6

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.47

0.89

1.9

1.6

60.6

63.3

0.13

(3026250) Tacrolimus [Mass/volume] in Blood

104

499

1.19

0.89

32.1

34.6

ug/l

7.3

7.1

0.45

457

(3009871) Measles virus Ab [Titer] in Serum

648

0.84

0.89

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

444

2332

1.08

0.89

2.5

2.7

umol/l

31.9

33.5

0.74

371

1972

(3023323) Follitropin [Units/volume] in Serum or Plasma

2361

12991

1.04

0.89

1.3

iu/l

32.4

33.4

0.73

2083

11457

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

308

1.24

0.88

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

805

4320

1.06

0.88

2.0

2.1

ug/l

479.5

444.0

0.11

730

3959

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

234

1192

1.12

0.88

1.3

mmol/l

2.1

0.15

217

1097

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

222

1128

1.12

0.87

1.3

1.2

u/l

79.4

83.2

0.30

196

997

(3025315) Body weight

1.44

0.87

4.4

4.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

341

0.78

0.87

2.3

2.9

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

0.56

0.87

1.0

1.2

ug/g

114.6

169.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

119

580

1.17

0.86

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

872

4695

1.06

0.86

2.8

3.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

109

1.41

0.86

1.0

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

228

1.27

0.85

1.2

nmol/l

0.4

0.3

0.17

147

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

176

884

1.13

0.85

1.3

u/l

291.8

401.3

1.64

163

836

(3003434) Protein [Mass/volume] in Pleural fluid

266

1369

1.11

0.84

1.4

g/l

33.7

33.2

0.24

240

1242

(3051651) Icteric interference index of Serum or Plasma

137

893

0.87

0.83

3.1

3.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

224

1.27

0.83

1.2

1.1

—

0.9

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

134

662

1.15

0.82

1.6

1.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.50

0.81

1.0

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.48

0.81

1.1

—

(3003694) ABO and Rh group [Type] in Blood

7194

40253

1.02

0.81

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

114

558

1.16

0.80

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1323

7216

1.04

0.80

1.1

u/ml

0.9

2.7

1.09

120

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

111

1.38

0.79

1.1

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

738

3967

1.06

0.79

2.2

g/l

0.0

0.03

659

3615

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

108

0.63

0.79

1.0

u/ml

0.3

0.4

0.16

(3024869) Neuronal Ab [Presence] in Serum

236

1.25

0.79

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

674

3614

1.06

0.79

2.2

g/l

0.0

0.00

609

3304

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

146

729

1.14

0.78

1.5

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1579

8649

1.04

0.78

1.1

titre

155.2

212.8

0.43

195

(3004716) Salmonella sp identified in Stool by Organism specific culture

1660

9103

1.04

0.78

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

189

960

1.12

0.78

1.1

nmol/l

2.6

5.9

0.60

172

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

128

833

0.87

0.78

1.2

1.4

—

(3045788) Cell count panel - Pleural fluid

189

962

1.12

0.76

1.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

520

0.84

0.76

1.0

1.1

u/ml

11.2

8.1

0.26

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

110

540

1.16

0.76

2.0

2.1

ug/min

41.1

42.2

0.02

101

(3017446) Testosterone [Moles/volume] in Serum or Plasma

182

1156

0.89

0.75

1.4

1.3

nmol/l

1.0

1.2

1.12

148

919

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.55

0.75

1.0

—

(40763590) HLA-DQ beta [Type]

1.55

0.75

1.1

1.0

—

(40760410) HLA-B [Type] by High resolution

1.55

0.75

1.1

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.55

0.75

1.1

1.0

—

(40760409) HLA-A [Type] by High resolution

1.55

0.75

1.1

1.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

404

1.18

0.74

1.3

1.4

umol/l

17.5

17.9

0.41

354

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.46

0.74

2.3

1.4

umol/24h

379.5

304.9

0.60

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

140

701

1.14

0.74

1.9

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

140

701

1.14

0.74

1.9

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

140

701

1.14

0.74

1.9

1.6

—

(3026726) Creatinine [Moles/volume] in Specimen

1.44

0.73

1.6

2.8

umol/l

776.4

448.7

0.41

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

117

579

1.15

0.73

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.03

0.72

4.0

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

250

1296

1.10

0.72

1.8

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

228

1177

1.10

0.72

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

524

2799

1.07

0.71

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

113

559

1.15

0.71

9.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2772

15362

1.03

0.71

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

265

1379

1.09

0.71

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.52

0.71

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

240

1.23

0.70

1.9

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

140

704

1.13

0.70

1.9

1.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

153

976

0.89

0.70

1.0

u/ml

0.2

0.35

109

(3034891) Synovial lining cells/100 cells in Synovial fluid

148

747

1.13

0.70

1.5

3.4

3.9

0.18

155

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

189

968

1.11

0.70

2.5

e6/l

648.4

885.1

1.25

417

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

3263

18129

1.03

0.70

1.6

1.7

—

(3010503) CD19 cells [#/volume] in Blood

167

850

1.12

0.69

2.6

2.5

e9/l

0.2

0.3

0.55

161

829

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

194

996

1.11

0.69

1.2

1.3

titre

635.6

467.9

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

104

0.66

0.68

1.1

1.0

u/ml

5.7

11.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

135

866

0.89

0.68

1.1

—

(44813793)

258

1344

1.09

0.68

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

362

1913

1.08

0.68

1.6

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

111

551

1.15

0.68

2.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

250

1302

1.09

0.67

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2513

13922

1.03

0.67

1.2

iu/ml

142.7

151.9

0.43

945

5598

(3022475) Manganese [Moles/volume] in Blood

130

1.31

0.66

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

237

1472

0.91

0.66

2.4

2.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

885

4811

1.05

0.66

2.0

1.9

ug/l

1.8

2.1

0.58

749

4217

(3019977) pH of Arterial blood

135

681

1.13

0.66

3.0

2.6

7.4

0.08

225

(3011897) Casein IgE Ab [Units/volume] in Serum

277

0.80

0.66

1.2

u/ml

0.1

9.9

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

591

0.87

0.65

3.0

umol/l

28.6

28.0

0.15

442

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

270

1414

1.09

0.65

1.7

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

232

1207

1.09

0.64

2.2

2.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

987

5383

1.04

0.64

4.5

0.9

0.01

921

5056

(3020891) Body temperature

904

5368

0.96

0.64

4.6

4.4

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.78

0.64

2.4

1.8

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.78

0.64

1.2

4.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.78

0.64

1.0

1.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.50

0.63

3.2

2.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

713

4256

0.95

0.63

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

577

3107

1.06

0.63

1.6

1.5

—

(3008898) HLA-B27 [Presence]

1173

6424

1.04

0.63

1.1

—

(3026906) Gabapentin [Moles/volume] in Serum or Plasma

0.00

0.63

0.0

1.0

—

62.1

—

(3001556) Androgen free Index in Serum or Plasma

0.64

0.63

1.0

1.1

—

(3035880) pH of Pleural fluid

108

539

1.14

0.63

1.1

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

251

1313

1.09

0.62

2.5

2.9

mg/l

34.1

44.1

0.31

161

883

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

486

2605

1.06

0.62

5.0

5.2

iu/ml

711.9

837.4

0.20

385

(3006598) pH of Arterial cord blood

0.00

0.62

0.0

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

474

2539

1.06

0.62

1.2

1.3

u/ml

48.4

60.2

0.51

193

(3000060) B lymphocytes [#/volume] in Blood

448

0.85

0.62

1.7

2.0

e6/l

789.5

193.4

0.56

253

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.37

0.62

1.0

u/l

42.8

51.0

0.29

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

459

2457

1.06

0.62

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

260

1.20

0.62

1.1

u/ml

0.5

0.2

0.23

162

(42529582) MDA5 Ab [Presence] in Serum by Line blot

386

1.16

0.61

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

386

1.16

0.61

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

386

1.16

0.61

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

386

1.16

0.61

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

193

1.24

0.61

4.9

9.9

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1516

8349

1.03

0.61

1.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

274

0.81

0.61

1.4

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

255

0.80

0.61

1.7

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

0.61

0.60

1.6

2.4

—

20.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2612

15207

0.97

0.60

1.8

1.7

—

(3000991) Gas panel - Venous blood

1919

10612

1.03

0.60

7.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

250

1311

1.09

0.60

2.2

2.1

u/field

2.8

2.5

0.24

122

543

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

616

3330

1.05

0.60

2.9

2.8

mg/l

1.5

0.76

558

3064

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

997

5451

1.04

0.60

4.4

1.5

1.7

5.26

929

5121

(3033923) Metanephrine [Moles/time] in 24 hour Urine

382

1.16

0.59

1.1

umol/24h

0.8

0.6

0.32

189

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

236

1235

1.09

0.59

1.2

titre

191.2

176.4

0.11

217

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5522

31880

0.98

0.59

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

689

4106

0.95

0.59

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

316

0.83

0.59

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2058

11398

1.03

0.58

2.6

2.7

ng/l

168.1

172.0

0.15

1866

10376

(21494815) CD4 cells/100 lymphocytes in Specimen

218

1138

1.09

0.58

2.0

44.1

43.3

0.11

161

(3036782) Glucose [Moles/volume] in Pleural fluid

191

991

1.10

0.58

1.2

1.3

mmol/l

6.5

0.11

175

928

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.71

0.58

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

161

829

1.10

0.57

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

188

976

1.10

0.57

1.2

1.3

titre

41.1

54.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

237

1244

1.08

0.56

1.1

iu/ml

7.2

8.7

0.36

305

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.69

0.56

1.0

—

(3004451) EKG impression Narrative

120

609

1.12

0.56

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

206

1.21

0.56

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1413

8287

0.97

0.55

6.5

6.4

mmol/l

24.8

0.08

1305

7709

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

234

1229

1.08

0.55

1.2

titre

314.0

172.1

—

(3048879) Bone marrow aspiration report

343

1.16

0.54

1.9

1.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

995

5455

1.04

0.54

1.7

1.8

g/l

0.2

0.43

938

5157

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.53

0.54

1.1

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

379

2029

1.06

0.54

1.2

1.1

—

(3034426) Prothrombin time (PT)

104

525

1.13

0.54

1.2

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

275

1.18

0.54

4.9

5.1

u/l

50.9

44.8

0.22

120

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.46

0.54

1.2

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

146

752

1.10

0.53

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

429

1.14

0.53

3.1

3.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

547

3267

0.95

0.53

1.2

u/l

19.4

17.0

2.12

461

2660

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

121

765

0.90

0.52

1.6

—

(40765096) Chromosome analysis panel by Banding

318

1.16

0.52

1.2

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1021

5607

1.04

0.51

1.6

1.8

g/l

1.2

1.46

968

5323

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

552

2993

1.05

0.51

1.6

1.5

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.62

0.50

1.0

1.4

—

14639.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

515

2790

1.05

0.49

1.1

au/ml

17.5

11.2

0.55

164

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

109

690

0.90

0.49

1.3

1.2

g/l

0.3

0.61

542

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

336

1.15

0.49

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

316

1689

1.06

0.49

1.4

g/l

0.4

0.06

217

1215

(3028192) IgG subclass 2 [Mass/volume] in Serum

316

1689

1.06

0.49

1.4

g/l

2.8

2.9

0.25

214

1210

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

180

942

1.09

0.49

1.1

u/l

1.0

1.1

0.74

405

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

144

897

0.91

0.48

1.1

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

133

831

0.91

0.48

1.2

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

316

1691

1.06

0.48

1.4

g/l

6.3

6.7

1.24

214

1215

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.60

0.47

1.2

1.0

—

(44806071)

227

0.83

0.46

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

250

1330

1.07

0.46

1.1

1.2

mg/l

41.7

39.3

0.22

208

1122

(3001019) Free T4 and TSH panel - Serum or Plasma

1964

11420

0.98

0.45

1.8

—

(4062490)

316

1695

1.06

0.45

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

231

1406

0.93

0.45

1.3

u/ml

0.6

1.2

1.08

107

607

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

149

1.22

0.45

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

164

859

1.09

0.45

1.3

1.2

u/l

243.7

263.0

0.11

154

804

(4306422)

455

2466

1.05

0.45

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

196

1.19

0.45

1.2

mmol/l

2.1

1.9

0.16

120

(3013005) Retinol [Moles/volume] in Serum or Plasma

135

701

1.10

0.45

1.6

umol/l

2.0

0.08

127

652

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

234

1244

1.07

0.44

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.67

0.44

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

226

1375

0.93

0.44

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

305

1637

1.06

0.43

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

383

1.13

0.43

1.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

155

1.21

0.43

1.2

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1133

6259

1.03

0.43

3.1

3.0

mmol/l

25.6

25.5

0.72

1104

6074

(44790048)

245

1485

0.94

0.43

1.4

1.5

—

(44790047)

245

1485

0.94

0.43

1.4

1.5

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.43

0.0

1.2

—

64.0

—

(44790049)

245

1484

0.94

0.42

1.4

1.5

—

(44806118)

245

1484

0.94

0.42

1.4

1.5

—

(3022670) pH of Venous cord blood

0.00

0.42

0.0

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1227

6789

1.03

0.42

8.3

8.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1069

5903

1.03

0.42

1.7

1.9

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

140

1.22

0.42

1.1

u/ml

3.2

2.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

293

1.15

0.42

1.3

mmol/l

3.2

0.04

274

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

208

1266

0.93

0.42

1.3

mmol/l

12.3

11.2

0.62

308

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

241

1286

1.07

0.42

1.1

mg/l

256.3

238.4

0.58

212

1130

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

162

995

0.93

0.42

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

100

514

1.11

0.42

1.4

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

327

1762

1.06

0.41

1.1

iu/ml

1.1

1.9

—

(3014345) clomiPRAMINE [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

4.1

—

381.4

—

(3042517) Benzodiazepines panel - Urine

137

0.79

0.41

1.5

2.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.66

0.41

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

151

1.21

0.41

1.0

u/ml

0.5

0.0

0.45

(3022689) Creatine [Moles/volume] in Urine

423

1.12

0.40

1.3

1.5

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.37

0.40

1.2

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

121

751

0.92

0.40

1.3

nmol/l

29.8

30.5

0.09

112

650

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

188

1.18

0.40

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.33

0.40

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

183

1.18

0.40

1.2

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

359

1.12

0.40

1.1

mg/g

8.5

5.9

1.43

338

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

284

1.14

0.39

1.6

1.1

—

(3020491) Glucose [Moles/volume] in Blood

180

1098

0.93

0.39

2.0

1.7

mmol/l

6.9

6.7

0.42

117

771

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.38

0.39

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

131

1.22

0.39

1.6

1.9

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.42

0.39

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

152

1.20

0.39

1.7

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

445

2423

1.05

0.39

1.2

1.3

—

(3034614) HLA Ag [Interpretation]

1.35

0.38

1.0

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

189

1.17

0.38

1.5

1.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

165

873

1.08

0.38

1.9

1.8

u/field

2.3

2.0

0.25

129

607

(3006245) CD3-CD19+ cells/100 cells in Blood

600

0.91

0.38

1.8

2.0

9.3

9.5

0.06

556

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

582

0.91

0.38

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.48

0.37

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.48

0.37

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.48

0.37

1.0

titre

1120.0

2174.8

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.48

0.37

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.48

0.37

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.48

0.37

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.48

0.37

2.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.62

0.37

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

101

1.24

0.36

1.3

ug/l

122.1

110.1

0.11

(3037692) Legionella sp identified in Specimen by Organism specific culture

459

1.10

0.36

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

169

1.18

0.36

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

239

0.86

0.36

1.7

1.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

275

0.87

0.36

1.0

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2761

15461

1.02

0.35

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

177

0.84

0.35

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

133

1.20

0.35

1.1

—

(3018133) Calcium [Moles/volume] in Urine

245

1.14

0.34

1.7

1.6

mmol/l

2.6

2.8

0.28

216

(3003396) Base excess in Arterial blood by calculation

2650

14842

1.02

0.34

6.2

6.4

mmol/l

1.1

1.3

1.73

2131

11760

(3016650) Hepatitis A virus Ab [Presence] in Serum

438

2394

1.04

0.34

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

144

1.18

0.34

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

101

527

1.09

0.34

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.36

0.33

1.2

1.1

nmol/l

379.2

276.9

0.49

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

321

1.12

0.33

1.3

—

(3017569) Oxygen content in Arterial blood

106

555

1.09

0.33

2.3

2.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

143

758

1.07

0.33

1.2

1.3

55.5

60.0

0.21

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

446

0.91

0.33

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.78

0.32

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

512

1.09

0.32

1.2

nmol/l

60.6

60.2

0.03

505

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

129

1.19

0.32

1.2

1.3

u/l

35.4

331.2

0.67

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

343

2036

0.96

0.32

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

316

1718

1.05

0.32

1.3

1.5

—

(3045177) Copper [Moles/volume] in Urine

1.37

0.32

1.3

1.1

umol/l

0.8

0.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

302

0.88

0.32

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

328

1785

1.05

0.32

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1784

10328

0.98

0.32

1.5

1.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

103

1.21

0.32

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

212

1141

1.06

0.32

1.3

1.5

u/ml

17.0

23.4

1.69

219

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2646

14832

1.02

0.31

6.2

6.5

kpa

5.1

0.15

2516

14152

(3019420) Tryptase [Mass/volume] in Serum or Plasma

178

953

1.06

0.31

1.4

1.5

ug/l

8.1

7.9

0.05

159

859

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

121

639

1.08

0.31

1.3

1.2

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

156

1.17

0.31

7.4

6.1

umol/l

0.4

0.5

0.18

136

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

385

0.90

0.31

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

285

1.12

0.31

1.5

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1041

5784

1.02

0.31

3.8

3.6

47.7

47.9

0.08

1029

5732

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.28

0.30

4.1

5.1

mmol/l

0.3

0.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2644

14828

1.02

0.30

6.2

6.5

kpa

12.9

12.8

0.36

2509

14143

(3050794) Legionella sp Ab [Presence] in Serum

109

1.20

0.30

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.23

0.30

1.0

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.23

0.30

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

105

553

1.08

0.30

1.2

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

112

0.81

0.29

8.9

5.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

214

1156

1.05

0.29

1.7

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

214

1156

1.05

0.29

1.7

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

214

1156

1.05

0.29

1.7

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

477

1.09

0.29

1.0

1.1

u/ml

2.4

0.9

0.37

247

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.30

0.28

1.1

—

(44806420)

341

1.10

0.28

2.2

2.4

—

(3016750) Collection duration of Urine

115

701

0.93

0.28

2.2

2.1

min

491.7

501.2

0.52

543

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.76

0.28

1.1

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

163

1.15

0.28

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

445

1.09

0.28

2.0

1.9

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

275

0.89

0.28

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

275

0.89

0.28

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

184

991

1.06

0.28

1.6

1.5

umol/l

60.1

63.6

0.54

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.74

0.28

1.1

1.2

—

(3023410) Appearance of Cerebral spinal fluid

277

1644

0.96

0.28

1.3

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.22

0.27

1.7

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

129

688

1.07

0.27

1.1

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.29

0.27

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

189

1131

0.95

0.27

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.66

0.27

1.6

2.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

365

2002

1.04

0.27

1.1

g/l

1.5

1.03

329

1800

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.23

0.26

1.2

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.80

0.26

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

279

0.90

0.26

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

151

908

0.95

0.26

2.2

692.6

622.1

1.21

101

657

(3000492) Spirometry study

2702

15181

1.01

0.26

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

279

1524

1.04

0.25

1.3

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.24

0.25

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

1.19

0.25

1.2

—

(4034850)

973

5422

1.02

0.25

8.4

9.0

—

(3019060) Gas panel - Arterial blood

1474

8519

0.98

0.25

4.5

4.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

317

1.09

0.25

1.0

ug/l

81.9

80.3

0.11

253

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

149

1.15

0.25

1.2

1.3

12.8

11.6

0.09

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

172

1028

0.95

0.24

1.7

1.8

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

236

0.89

0.24

1.9

2.6

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

164

0.87

0.24

1.2

mmol/l

0.3

2.1

2.91

107

(44786800) Granulocytes/100 leukocytes in Body fluid

128

1.16

0.24

1.3

1.2

23.8

22.5

0.06

105

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

134

720

1.06

0.24

2.6

2.8

41.9

42.8

0.17

262

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.35

0.24

1.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2169

12178

1.01

0.24

6.9

7.1

g/l

119.4

118.8

0.62

2079

11735

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.28

0.24

2.7

3.2

—

(3016502) Oxygen saturation in Arterial blood

2309

12970

1.01

0.24

6.5

6.8

96.1

95.9

0.78

2217

12462

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

442

2440

1.03

0.24

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

207

1126

1.05

0.24

1.3

1.2

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

1.29

0.23

1.4

1.5

umol/l

2904.0

2817.3

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.29

0.23

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

204

1.12

0.23

1.2

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

298

1756

0.96

0.23

1.1

93.4

95.8

0.87

281

1640

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

217

0.89

0.23

1.1

—

(3014891) Appearance of Pleural fluid

157

0.87

0.23

1.5

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

181

0.88

0.23

1.0

u/ml

0.1

0.2

0.78

108

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

181

0.88

0.23

1.1

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

591

3279

1.03

0.23

1.3

1.4

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.81

0.23

1.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

602

3507

0.98

0.22

1.4

e6/l

1696.7

1588.2

0.06

496

2850

(3013293) Extractable nuclear Ab [Presence] in Serum

341

1.08

0.22

1.5

1.6

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.2

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.22

0.0

1.3

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.22

0.0

1.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

104

628

0.94

0.22

1.2

113.3

113.1

0.03

551

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.20

0.21

2.6

4.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1147

6416

1.02

0.21

1.7

mg/l

3.2

3.3

0.29

820

4622

(40758358) Immune stain study

108

1.16

0.21

1.0

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

5.5

—

(3047181) Lactate [Moles/volume] in Blood

763

4252

1.02

0.21

4.8

5.1

mmol/l

1.3

0.54

664

3766

(3002331) Protein [Mass/volume] in Peritoneal fluid

263

0.91

0.21

1.5

1.3

g/l

25.7

29.6

0.81

204

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

892

5166

0.98

0.21

1.1

u/ml

4.7

5.8

0.29

108

664

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.26

0.21

1.5

1.0

1.7

2.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

591

0.94

0.20

2.1

2.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

387

1.07

0.20

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

195

1065

1.04

0.20

1.1

ratio

1.1

0.11

379

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.16

0.20

1.2

20.2

19.7

—

(3002619) Bacteria identified in Specimen by Culture

305

1.08

0.20

1.2

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

201

1.10

0.20

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

173

1026

0.96

0.20

1.8

1.9

—

(3051101) Glucose [Moles/volume] in Cord blood

244

0.91

0.20

4.9

5.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

136

1.13

0.19

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

173

1025

0.96

0.19

1.1

1.2

mmol/l

34.7

32.5

0.52

140

871

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

603

3502

0.98

0.19

1.3

1.4

e6/l

24.1

34.2

0.66

470

2710

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

273

0.92

0.19

1.6

2.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.82

0.19

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.82

0.19

1.6

1.5

u/l

0.0

0.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

169

1.11

0.19

1.7

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

505

1.06

0.19

3.7

3.2

mg/l

4636.8

783.7

0.62

358

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

389

1.07

0.18

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

399

2327

0.97

0.18

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

440

2561

0.98

0.17

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

148

1.11

0.17

1.0

u/ml

0.0

0.90

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.19

0.17

11.7

7.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.17

0.17

1.0

—

(3001729) Color of Synovial fluid

123

0.88

0.17

1.7

1.8

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

209

1.09

0.16

2.3

2.1

—

(3008295) Osmolality of Serum or Plasma

256

1499

0.97

0.16

1.5

mosm/kgh2o

277.8

276.9

0.28

191

1152

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

138

1.11

0.16

1.0

u/ml

0.1

0.7

0.92

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

182

0.91

0.16

1.1

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

141

770

1.04

0.16

1.4

nmol/l

136.7

133.0

0.51

141

770

(3001964) Herpes simplex virus Ag [Presence] in Specimen

475

1.05

0.16

1.4

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

440

2556

0.98

0.16

1.1

—

(3023419) Bacteria identified in Sputum by Culture

297

1645

1.03

0.16

2.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

734

4107

1.02

0.16

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.16

0.16

1.0

1.1

—

(4027681)

188

1034

1.03

0.15

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

119

706

0.96

0.15

1.8

2.0

ug/l

70.9

55.3

1.17

114

689

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

134

0.89

0.15

1.1

nmol/l

11.5

14.6

—

(40758292) HTLV I+II Ab panel - Serum

188

1.09

0.15

1.5

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

371

2063

1.02

0.15

1.5

1.6

iu/ml

37.0

34.6

0.08

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

454

1.05

0.15

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.17

0.15

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

141

832

0.96

0.14

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

559

0.96

0.14

4.3

3.9

u/ml

259.4

1465.5

0.45

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

189

1.08

0.14

1.1

umol/24h

1.6

0.18

189

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.14

0.14

1.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

283

1.07

0.14

1.3

g/l

14.8

13.9

0.24

219

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

472

2636

1.02

0.13

1.1

u/ml

3.2

2.8

0.26

208

1303

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

1.15

0.13

1.0

1.1

mg/l

0.0

0.61

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

152

836

1.03

0.13

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

103

0.88

0.13

1.0

1.4

ml/s/173m2

1.2

2.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

355

0.95

0.13

1.3

1.2

mg/l

0.7

38.1

1.38

257

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

428

2389

1.02

0.13

1.1

125.4

123.9

0.39

383

2145

(3011412) CD3 cells [#/volume] in Blood

257

1426

1.03

0.13

2.3

e9/l

1.3

1.2

0.57

156

863

(43055514) Macroprolactin [Presence] in Serum or Plasma

378

0.95

0.13

1.3

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

540

1.04

0.13

2.7

2.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

501

1.04

0.13

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

384

1.05

0.13

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

384

1.05

0.13

1.2

—

(3019150) Specific gravity of Urine by Refractometry

6080

34717

0.99

0.13

4.4

4.3

kg/l

1.0

1.04

969

5291

(3001893) Eosinophils/100 leukocytes in Pleural fluid

301

1.06

0.12

1.3

2.6

2.8

0.05

255

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

195

1079

1.03

0.12

1.4

1.3

umol/l

10.9

11.2

0.24

184

1033

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

870

4891

1.01

0.12

1.6

iu/ml

2.6

7.3

0.45

173

1002

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

102

0.89

0.12

1.3

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

391

1.05

0.11

1.1

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

213

1.07

0.11

3.0

2.4

mg/l

37.6

42.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

470

2631

1.02

0.11

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

208

1154

1.03

0.11

1.6

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

442

2554

0.98

0.11

1.2

u/ml

3.0

3.5

0.19

120

837

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

397

1.05

0.11

3.1

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

397

1.05

0.11

3.1

2.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

110

604

1.04

0.11

1.5

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

110

604

1.04

0.11

1.5

1.4

—

(4268621)

295

1645

1.02

0.11

2.3

2.2

—

(3015183) Erythrocyte sedimentation rate

156

911

0.97

0.10

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.18

0.10

6.6

8.4

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

148

0.92

0.10

1.0

u/ml

0.2

1.8

0.54

105

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

175

971

1.03

0.10

1.4

1.3

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

1.14

0.10

1.6

1.3

nmol/l

185.4

173.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

498

2794

1.01

0.10

2.3

ug/min

78.9

61.4

0.47

270

1578

(3029612) Listeria sp Ab [Titer] in Serum

1.09

0.10

1.0

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

285

1650

0.98

0.09

2.9

3.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.89

0.09

1.0

—

25.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

477

2677

1.01

0.09

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

268

1497

1.02

0.09

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.88

0.09

1.2

1.1

u/l

300.5

537.4

0.45

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

246

0.95

0.09

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

112

0.91

0.09

1.1

u/l

9.4

10.3

0.10

112

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

425

0.96

0.09

1.5

2.1

ug/l

2.7

4.1

0.44

267

(3018572) Chloride [Moles/volume] in Blood

515

2964

0.99

0.09

5.8

5.9

mmol/l

105.1

0.05

456

2669

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.07

0.09

1.3

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

141

0.93

0.09

1.5

mg/l

2.1

1.8

0.16

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

141

0.93

0.09

1.5

mg/l

3.1

4.2

0.36

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

141

0.93

0.09

1.5

mg/l

1.1

1.0

0.07

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

141

0.93

0.09

1.5

mg/l

4.3

2.0

0.60

108

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

141

0.93

0.09

1.5

mg/l

1.3

2.5

0.91

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

141

0.93

0.09

1.5

mg/l

3.8

2.7

0.26

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

141

0.93

0.09

1.5

mg/l

2.9

2.5

0.08

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

141

0.93

0.09

1.5

mg/l

0.7

0.9

0.22

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

141

0.93

0.09

1.5

mg/l

1.3

1.7

0.39

(3044007) Cell count panel - Peritoneal fluid

361

1.04

0.08

2.2

1.8

—

(3039000) Anion gap in Blood

515

2963

0.99

0.08

5.8

5.9

mmol/l

11.1

11.0

0.32

456

2668

(3006567) Chloride [Moles/time] in 24 hour Urine

1.03

0.08

1.0

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

129

715

1.03

0.08

1.4

pmol/l

15.0

14.5

0.60

105

599

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

0.91

0.08

1.1

1.0

u/ml

0.2

0.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

485

1.03

0.08

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

336

1938

0.99

0.08

1.2

—

(3019174) dRVVT (LA screen)

152

0.94

0.08

1.3

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.81

0.08

56.8

8.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

337

0.96

0.08

4.9

5.6

mmol/l

24.3

25.6

1.33

307

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

479

2694

1.01

0.07

1.4

1.3

u/ml

18.1

22.5

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

146

0.93

0.07

1.5

mg/l

0.9

2.1

1.56

(3045716) Anion gap in Serum or Plasma

106

587

1.03

0.07

3.0

2.3

mmol/l

9.2

9.1

0.12

433

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.03

0.07

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

140

0.93

0.07

1.4

1.5

mmol/l

6.3

7.4

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.87

0.07

2.3

2.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

357

1.04

0.07

1.3

61.3

62.9

0.14

303

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.09

0.07

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.92

0.07

1.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

178

1.05

0.07

1.7

mg/l

1.4

1.6

0.37

150

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

363

1.03

0.07

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.87

0.07

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.88

0.06

1.2

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

187

1081

0.98

0.06

1.9

2.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

145

0.94

0.06

1.0

u/ml

0.0

0.4

0.88

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

559

0.98

0.06

4.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

513

0.98

0.06

1.7

mg/l

8.9

9.7

0.59

406

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

235

1.04

0.06

1.3

1.2

ug/l

639.6

257.0

0.39

145

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

346

1947

1.01

0.06

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

146

816

1.02

0.05

1.1

u/ml

22.4

10.9

0.36

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1347

7624

1.00

0.05

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

482

2718

1.01

0.05

1.4

1.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

204

1144

1.01

0.05

1.9

2.0

73.3

74.2

0.44

197

1100

(3041672) Baker's yeast Ab [Presence] in Serum

0.91

0.05

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

264

1519

0.99

0.05

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

264

1519

0.99

0.05

1.1

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

118

684

0.98

0.05

1.2

1.1

iu/ml

3.2

3.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

427

1.03

0.05

1.6

au/ml

135.3

148.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

397

0.97

0.05

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.07

0.05

1.1

u/ml

1.2

3.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

549

3144

0.99

0.05

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

549

3144

0.99

0.05

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

180

1.04

0.05

1.2

1.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

109

0.94

0.04

1.7

2.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

1418

8033

1.00

0.04

7.8

8.1

94.2

94.0

0.79

1413

8001

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

197

1.04

0.04

6.0

4.8

ug/min

47.0

34.0

0.49

143

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

517

2920

1.01

0.04

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

379

0.98

0.04

1.2

1.3

nmol/l

130.8

116.0

0.38

268

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

496

1.02

0.04

1.3

35.7

19.4

1.07

(40757494) Bilirubin.total [Moles/volume] in Blood

125

722

0.98

0.04

2.1

umol/l

18.4

13.8

0.70

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

616

3483

1.01

0.04

1.2

mmol/l

3.7

0.11

579

3265

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

158

910

0.99

0.04

1.0

ng/l

41.0

45.2

0.46

120

642

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

290

1635

1.01

0.04

1.2

—

(3003181) Sodium [Moles/volume] in Urine

479

2741

0.99

0.04

1.4

mmol/l

60.5

61.3

0.18

384

2162

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

435

2490

0.99

0.04

1.4

1.3

u/ml

130.9

113.9

0.80

611

(3017143) Hepatitis C virus Ab [Presence] in Serum

2904

16549

1.00

0.04

1.6

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

305

1.03

0.04

1.2

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

142

818

0.99

0.03

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

265

1520

0.99

0.03

1.1

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1410

7993

1.00

0.03

7.8

8.1

0.7

0.17

1402

7947

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

184

1035

1.01

0.03

2.4

2.3

e6/l

487.4

533.4

0.45

155

864

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.94

0.03

1.0

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

200

1126

1.01

0.03

1.9

2.0

14.6

13.8

0.44

553

(40759836) Histone Ab [Presence] in Serum by Immunoblot

262

1502

0.99

0.03

1.1

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

112

646

0.99

0.03

4.0

2.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

154

0.96

0.03

1.3

1.2

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.94

0.03

1.3

mg/l

1.2

1.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

481

1.02

0.03

2.8

2.9

mg/l

8.3

8.0

0.15

379

(3049242) von Willebrand panel - Platelet poor plasma

1.09

0.03

2.3

1.7

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

125

702

1.01

0.03

1.1

miu/ml

1668.9

1517.2

0.68

125

702

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1408

8028

1.00

0.03

7.8

8.0

1.3

1.4

1.63

1400

7976

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

696

3942

1.00

0.03

1.3

mg/l

550.9

508.3

0.49

668

3764

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

271

1552

0.99

0.03

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

131

1.04

0.03

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

165

1.03

0.02

13.3

11.0

mmol/l

4.8

4.7

0.16

165

(3020874) Milk IgE Ab [Units/volume] in Serum

194

1112

0.99

0.02

1.0

1.1

u/ml

0.4

3.0

0.75

291

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

250

1431

0.99

0.02

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

263

1505

0.99

0.02

1.1

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.06

0.02

1.1

1.3

mmol/l

24.4

23.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

175

1003

0.99

0.02

2.5

2.4

e9/l

0.3

0.2

1.17

154

862

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

112

630

1.01

0.02

1.1

ng/l

153.5

621.3

0.96

146

(3017704) Immunofixation for Urine

121

695

0.99

0.02

1.7

—

(3046861) Legionella sp Ag [Presence] in Urine

0.93

0.02

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

109

1.04

0.02

1.1

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

126

1.04

0.02

1.6

1.9

umol/l

44.0

48.4

0.33

126

(3002621) Streptococcal DNAse B [Units/volume] in Serum

107

0.96

0.02

1.1

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

147

0.97

0.02

1.3

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

449

1.01

0.02

1.4

1.8

u/ml

167.0

46938.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

455

1.01

0.01

2.1

1.8

e6/l

2094.7

2499.1

0.08

288

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

158

905

0.99

0.01

1.0

ng/l

747.3

742.8

0.05

115

628

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

263

1503

1.00

0.01

1.1

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

156

893

0.99

0.01

1.3

1.5

promille

1.2

1.3

0.29

121

671

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

189

1.02

0.01

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

249

0.98

0.01

1.1

1.0

u/ml

0.2

0.4

0.28

169

(3033799) Differential panel - Peritoneal fluid

382

1.01

0.01

2.0

1.7

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

226

0.98

0.01

1.5

1.6

nmol/l

375008.4

282087.2

0.13

173

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

562

0.99

0.01

2.1

2.3

umol/l

54.4

52.5

0.25

445

(3010375) cycloSPORINE [Mass/volume] in Blood

539

0.99

0.01

26.1

27.6

ug/l

113.4

115.5

0.13

452

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

445

2525

1.00

0.01

1.3

1.2

u/ml

291.0

286.3

0.13

274

1687

(4133840)

351

0.99

0.01

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

436

2474

1.00

0.01

1.2

u/ml

4.5

3.8

0.52

164

1036

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

146

0.97

0.01

1.2

1.4

pmol/l

11.0

15.0

0.38

122

(40757373) Influenza virus identified in Isolate

275

1.01

0.00

1.5

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

214

0.98

0.00

2.0

1.3

52.8

53.6

0.04

114

(3024471) HLA-A [Type]

396

0.99

0.00

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

142

804

1.00

0.00

1.5

1.7

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

112

1.02

0.00

1.1

u/ml

0.0

0.4

1.12

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

403

1.00

0.00

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

119

1.00

0.00

1.1

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

442

1.00

0.00

2.3

2.4

au/ml

176.1

160.7

0.08

(3024932) HLA-DR beta [Type]

381

1.00

0.00

1.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

140

1.02

0.00

1.3

1.4

70.3

75.1

0.29

121

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

112

637

1.00

0.00

1.8

1.9

umol/l

141.4

139.6

0.02

354

(3042733) HLA Ab [Presence] in Serum

365

1.00

0.00

5.9

5.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

190

1080

1.00

0.00

1.0

u/ml

0.8

2.3

0.81

232

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

208

1.01

0.00

6.2

5.3

72.4

68.0

0.43

155

(3028717) Thiamine [Mass/volume] in Blood

176

1.00

0.00

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1863

10597

1.00

0.00

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

219

1247

1.00

0.00

3.9

3.8

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

158

896

1.00

0.00

1.0

ng/l

580.1

328.7

0.60

120

643

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

247

1.01

0.00

1.5

1.4

26.1

22.3

0.39

212

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

413

2348

1.00

0.00

1.6

1.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

438

1.00

0.00

1.3

1.5

41.0

50.7

1.40

368

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.97

0.00

1.2

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

109

0.99

0.00

1.0

u/ml

0.0

0.4

1.06

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

406

0.99

0.00

2.0

1.6

e6/l

18904.3

12038.2

0.22

196

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.02

0.00

1.1

1.0

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

152

863

1.00

0.00

1.3

umol/l

3.3

4.1

2.63

138

788

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

201

1144

1.00

0.00

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

165

1.00

0.00

1.2

1.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.97

0.00

1.1

1.0

g/l

0.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.93

0.00

1.0

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.00

0.00

1.0

1.1

—

(3006407) Chromogranin A [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

63.0

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.0

2.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.89

0.00

1.0

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.95

0.00

1.0

1.1

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.0

1.0

—

(40763791) Oxygen content in Venous blood by calculation

0.92

0.00

6.3

7.4

ml/dl

11.7

12.1

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.99

0.00

1.1

1.2

—

(1616488) Thyroxine (T4) free [Moles/volume] in Cord blood

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_LEIOMYOMA_UTERI and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_LEIOMYOMA_UTERI	0.867 [0.8, 0.94]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.274

During the follow-up period (1.1.1998 — 31.12.2019), 9080 out of 138246 females with CD2_BENIGN_LEIOMYOMA_UTERI died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_LEIOMYOMA_UTERI.

N-year risk	Females	Males
1	0.076%	No data
5	0.498%	No data
10	1.288%	No data
15	2.456%	No data
20	4.441%	No data

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_LEIOMYOMA_UTERI – Leiomyoma of uterus

GWS hits: 141

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Leiomyoma of uterus

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints